<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Toxins (Basel)</journal-id><journal-id journal-id-type="iso-abbrev">Toxins (Basel)</journal-id><journal-id journal-id-type="publisher-id">toxins</journal-id><journal-title-group><journal-title>Toxins</journal-title></journal-title-group><issn pub-type="epub">2072-6651</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39998090</article-id><article-id pub-id-type="pmc">PMC11860464</article-id>
<article-id pub-id-type="doi">10.3390/toxins17020073</article-id><article-id pub-id-type="publisher-id">toxins-17-00073</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>&#x003b1;-Latrotoxin Actions in the Absence of Extracellular Ca<sup>2+</sup> Require Release of Stored Ca<sup>2+</sup></article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-2171-6716</contrib-id><name><surname>Blackburn</surname><given-names>Jennifer K.</given-names></name><xref rid="af1-toxins-17-00073" ref-type="aff">1</xref><xref rid="fn1-toxins-17-00073" ref-type="author-notes">&#x02020;</xref></contrib><contrib contrib-type="author"><name><surname>Islam</surname><given-names>Quazi Sufia</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><xref rid="af1-toxins-17-00073" ref-type="aff">1</xref><xref rid="fn2-toxins-17-00073" ref-type="author-notes">&#x02021;</xref></contrib><contrib contrib-type="author"><name><surname>Benlaouer</surname><given-names>Ouafa</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><xref rid="af1-toxins-17-00073" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Tonevitskaya</surname><given-names>Svetlana A.</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><xref rid="af2-toxins-17-00073" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Petitto</surname><given-names>Evelina</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review &#x00026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="af1-toxins-17-00073" ref-type="aff">1</xref><xref rid="fn3-toxins-17-00073" ref-type="author-notes">&#x000a7;</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-5712-8297</contrib-id><name><surname>Ushkaryov</surname><given-names>Yuri A.</given-names></name><xref rid="af1-toxins-17-00073" ref-type="aff">1</xref><xref rid="c1-toxins-17-00073" ref-type="corresp">*</xref></contrib></contrib-group><aff id="af1-toxins-17-00073"><label>1</label>Medway School of Pharmacy, University of Kent, Chatham ME4 4TB, UK; <email>jennifer.blackburn@yale.edu</email> (J.K.B.); <email>qsi@du.ac.bd</email> (Q.S.I.); <email>benlaouer.ouafa@gmail.com</email> (O.B.); <email>evelina.petitto@ashfiedmedcomms.com</email> (E.P.)</aff><aff id="af2-toxins-17-00073"><label>2</label>Faculty of Biology and Biotechnology, HSE University, Moscow 117418, Russia; <email>stonevitskaya@hse.ru</email></aff><author-notes><corresp id="c1-toxins-17-00073"><label>*</label>Correspondence: <email>y.ushkaryov@kent.ac.uk</email></corresp><fn id="fn1-toxins-17-00073"><label>&#x02020;</label><p>Current address: Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06511, USA.</p></fn><fn id="fn2-toxins-17-00073"><label>&#x02021;</label><p>Current address: Department of Pharmacology and Therapeutics, McGill University, Montreal, QC H3G 1Y6, Canada.</p></fn><fn id="fn3-toxins-17-00073"><label>&#x000a7;</label><p>Current address: Ashfield MedComms, Macclesfield SK11 7HQ, UK.</p></fn></author-notes><pub-date pub-type="epub"><day>06</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>2</month><year>2025</year></pub-date><volume>17</volume><issue>2</issue><elocation-id>73</elocation-id><history><date date-type="received"><day>06</day><month>1</month><year>2025</year></date><date date-type="rev-recd"><day>31</day><month>1</month><year>2025</year></date><date date-type="accepted"><day>04</day><month>2</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; 2025 by the authors.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>&#x003b1;-Latrotoxin (&#x003b1;LTX) causes exhaustive release of neurotransmitters from nerve terminals in the absence of extracellular Ca<sup>2+</sup> (Ca<sup>2+</sup><sub>e</sub>). To investigate the mechanisms underlying this effect, we loaded mouse neuromuscular junctions with BAPTA-AM. This membrane-permeable Ca<sup>2+</sup>-chelator demonstrates that Ca<sup>2+</sup><sub>e</sub>-independent effects of &#x003b1;LTX require an increase in cytosolic Ca<sup>2+</sup> (Ca<sup>2+</sup><sub>cyt</sub>). We also show that thapsigargin, which depletes Ca<sup>2+</sup> stores, induces neurotransmitter release, but inhibits the effect of &#x003b1;LTX. We then studied &#x003b1;LTX&#x02019;s effects on Ca<sup>2+</sup><sub>cyt</sub> using neuroblastoma cells expressing signaling-capable or signaling-incapable variants of latrophilin-1, a G protein-coupled receptor of &#x003b1;LTX. Our results demonstrate that &#x003b1;LTX acts as a cation ionophore and a latrophilin agonist. In model cells at 0 Ca<sup>2+</sup><sub>e</sub>, &#x003b1;LTX forms membrane pores and allows the influx of Na<sup>+</sup>; this reverses the Na<sup>+</sup>-Ca<sup>2+</sup> exchanger, leading to the release of stored Ca<sup>2+</sup> and inhibition of its extrusion. Concurrently, &#x003b1;LTX stimulates latrophilin signaling, which depletes a Ca<sup>2+</sup> store and induces transient opening of Ca<sup>2+</sup> channels in the plasmalemma that are sensitive to inhibitors of store-operated Ca<sup>2+</sup> entry. These results indicate that Ca<sup>2+</sup> release from intracellular stores and that Ca<sup>2+</sup> influx through latrophilin-activated store-operated Ca<sup>2+</sup> channels contributes to &#x003b1;LTX actions and may be involved in physiological control of neurotransmitter release at nerve terminals.</p></abstract><kwd-group><kwd>&#x003b1;-Latrotoxin</kwd><kwd>calcium</kwd><kwd>intracellular Ca<sup>2+</sup> stores</kwd><kwd>neurotransmitter release</kwd><kwd>neuromuscular junction</kwd><kwd>neuroblastoma cells</kwd><kwd>store-operated Ca<sup>2+</sup> entry</kwd><kwd>ADGRL1</kwd><kwd>latrophilin-1</kwd></kwd-group><funding-group><award-group><funding-source>University of Kent core fund and in part by a Wellcome Trust project</funding-source><award-id>GR074359</award-id></award-group><award-group><funding-source>Biotechnology and Biological Science Research Council Core Support</funding-source><award-id>28/B14085</award-id><award-id>BB/D523078/1</award-id></award-group><award-group><funding-source>University of Kent PhD studentships</funding-source></award-group><award-group><funding-source>Basic Research Program at HSE University, Moscow</funding-source></award-group><funding-statement>This research was mainly supported by a University of Kent core fund and in part by a Wellcome Trust project grant GR074359 and by Biotechnology and Biological Science Research Council Core Support grants 28/B14085 and BB/D523078/1 to Y.A.U.; J.K.B. and E.P. were funded by University of Kent PhD studentships; S.A.T. worked within the framework of the &#x0201c;Creation of Experimental Laboratories in Natural Sciences&#x0201d; Program and the Basic Research Program at HSE University, Moscow.</funding-statement></funding-group></article-meta><notes notes-type="Key Contribution"><title>Key Contribution</title><p>The role of Ca<sup>2+</sup><sub>e</sub> and Ca<sup>2+</sup><sub>cyt</sub> in the &#x003b1;LTX-induced release of neurotransmitters has been controversial. We demonstrate that &#x003b1;LTX actions on exocytosis strictly require Ca<sup>2+</sup><sub>cyt</sub>. This Ca<sup>2+</sup> is released from intracellular stores via two mechanisms: influx of Na<sup>+</sup> through the &#x003b1;LTX pores and latrophilin-mediated signaling. Thus, &#x003b1;LTX-evoked neurotransmitter exocytosis is caused by the increased Ca<sup>2+</sup><sub>cyt</sub> level and inhibition of Ca<sup>2+</sup> extrusion, and does not involve any novel exocytotic mechanisms.</p></notes></front><body><sec sec-type="intro" id="sec1-toxins-17-00073"><title>1. Introduction</title><p>&#x003b1;-Latrotoxin (&#x003b1;LTX) from black widow spider venom has been used for many years to study the complex mechanisms that underlie neurotransmitter release [<xref rid="B1-toxins-17-00073" ref-type="bibr">1</xref>,<xref rid="B2-toxins-17-00073" ref-type="bibr">2</xref>]. Soon after its first use as a molecular tool [<xref rid="B3-toxins-17-00073" ref-type="bibr">3</xref>], the toxin&#x02019;s complex activity was revealed [<xref rid="B4-toxins-17-00073" ref-type="bibr">4</xref>,<xref rid="B5-toxins-17-00073" ref-type="bibr">5</xref>] and, despite many examples of successful application of &#x003b1;LTX in neuronal studies [<xref rid="B6-toxins-17-00073" ref-type="bibr">6</xref>,<xref rid="B7-toxins-17-00073" ref-type="bibr">7</xref>,<xref rid="B8-toxins-17-00073" ref-type="bibr">8</xref>,<xref rid="B9-toxins-17-00073" ref-type="bibr">9</xref>], has so far remained enigmatic. The best-understood actions of &#x003b1;LTX include (i) its ability to form large, cation-permeable pores in cell membranes and (ii) the activation of the toxin&#x02019;s presynaptic receptor, the adhesion-class G protein-coupled receptor latrophilin 1 (LPHN1, or ADGRL1 in the new nomenclature) [<xref rid="B10-toxins-17-00073" ref-type="bibr">10</xref>]. These two actions occur concurrently but induce distinct patterns of neurotransmitter release [<xref rid="B11-toxins-17-00073" ref-type="bibr">11</xref>]. However, the exact mechanisms underlying &#x003b1;LTX actions remain unclear. Particularly puzzling is the ability of &#x003b1;LTX to cause massive exocytosis of neurotransmitters in the absence of extracellular Ca<sup>2+</sup> (Ca<sup>2+</sup><sub>e</sub>) [<xref rid="B1-toxins-17-00073" ref-type="bibr">1</xref>,<xref rid="B5-toxins-17-00073" ref-type="bibr">5</xref>], which has led some researchers to propose that &#x003b1;LTX induces a novel pathway of exocytosis that operates independently of both Ca<sup>2+</sup><sub>cyt</sub> and the conventional vesicle fusion machinery [<xref rid="B12-toxins-17-00073" ref-type="bibr">12</xref>].</p><p>&#x003b1;LTX is a large, tetrameric protein, with a propeller-like structure and mobile hydrophobic appendages at the base that facilitate its insertion into cell membranes [<xref rid="B13-toxins-17-00073" ref-type="bibr">13</xref>]. At its center, &#x003b1;LTX has a large, non-selective, cation-permeable pore, which is 10 &#x000c5; wide [<xref rid="B14-toxins-17-00073" ref-type="bibr">14</xref>,<xref rid="B15-toxins-17-00073" ref-type="bibr">15</xref>,<xref rid="B16-toxins-17-00073" ref-type="bibr">16</xref>]. Thus, &#x003b1;LTX was thought to trigger exocytosis by enabling an influx of Ca<sup>2+</sup> into presynaptic terminals through the pore it creates [<xref rid="B4-toxins-17-00073" ref-type="bibr">4</xref>]. This pore is also wide enough to permit non-vesicular leakage of cytosolic neurotransmitters [<xref rid="B17-toxins-17-00073" ref-type="bibr">17</xref>,<xref rid="B18-toxins-17-00073" ref-type="bibr">18</xref>], and this may be helped by imperfections in the two-dimensional crystals that &#x003b1;LTX tetramers can form within the membrane [<xref rid="B13-toxins-17-00073" ref-type="bibr">13</xref>]. Yet, these actions either require Ca<sup>2+</sup><sub>e</sub> or have a non-exocytotic character.</p><p>&#x003b1;LTX also stimulates exocytosis by activating presynaptic receptors. &#x003b1;LTX binds to ADGRL1 in the absence of Ca<sup>2+</sup> [<xref rid="B8-toxins-17-00073" ref-type="bibr">8</xref>], and activates a G&#x003b1;q/phospholipase C/inositol trisphosphate signaling cascade that causes mobilization of Ca<sup>2+</sup> from the endoplasmic reticulum (ER) [<xref rid="B19-toxins-17-00073" ref-type="bibr">19</xref>,<xref rid="B20-toxins-17-00073" ref-type="bibr">20</xref>,<xref rid="B21-toxins-17-00073" ref-type="bibr">21</xref>,<xref rid="B22-toxins-17-00073" ref-type="bibr">22</xref>]. The subsequent increase in cytosolic [Ca<sup>2+</sup>] ([Ca<sup>2+</sup>]<sub>cyt</sub>) triggers vesicular exocytosis. This effect is most clearly demonstrated when &#x003b1;LTX pore formation is prevented (i) by blocking toxin pores with La<sup>3+</sup> or (ii) by using the mutant toxin LTX<sup>N4C</sup>, which does not form pores [<xref rid="B19-toxins-17-00073" ref-type="bibr">19</xref>]. Surprisingly, to trigger exocytosis, the ADGRL1 signaling cascade still requires Ca<sup>2+</sup><sub>e</sub> [<xref rid="B18-toxins-17-00073" ref-type="bibr">18</xref>,<xref rid="B20-toxins-17-00073" ref-type="bibr">20</xref>]. Depletion of Ca<sup>2+</sup> stores is known to activate Stromal interaction molecule (STIM) proteins [<xref rid="B23-toxins-17-00073" ref-type="bibr">23</xref>,<xref rid="B24-toxins-17-00073" ref-type="bibr">24</xref>,<xref rid="B25-toxins-17-00073" ref-type="bibr">25</xref>,<xref rid="B26-toxins-17-00073" ref-type="bibr">26</xref>,<xref rid="B27-toxins-17-00073" ref-type="bibr">27</xref>], which trigger the opening of store-operated Ca<sup>2+</sup> channels (SOCCs) [<xref rid="B28-toxins-17-00073" ref-type="bibr">28</xref>,<xref rid="B29-toxins-17-00073" ref-type="bibr">29</xref>,<xref rid="B30-toxins-17-00073" ref-type="bibr">30</xref>] and induce store-operated Ca<sup>2+</sup><sub>e</sub> entry (SOCE) into cells. In support of a possible contribution of these channels to ADGRL1-mediated &#x003b1;LTX action, it can be blocked by SOCC inhibitors [<xref rid="B20-toxins-17-00073" ref-type="bibr">20</xref>].</p><p>&#x003b1;LTX has been reported to release Ca<sup>2+</sup> from intracellular stores even in the absence of Ca<sup>2+</sup><sub>e</sub>. Tsang et al. [<xref rid="B31-toxins-17-00073" ref-type="bibr">31</xref>] found that at frog nerve terminals, in Ca<sup>2+</sup>-free conditions, &#x003b1;LTX releases Ca<sup>2+</sup> from mitochondria (MC), which depends on Na<sup>+</sup> influx. Such a mechanism of Ca<sup>2+</sup> release could include the reversal of Na<sup>+</sup>/Ca<sup>2+</sup> exchanger (NCX) [<xref rid="B32-toxins-17-00073" ref-type="bibr">32</xref>,<xref rid="B33-toxins-17-00073" ref-type="bibr">33</xref>], one of the major Ca<sup>2+</sup> extrusion pumps located on the plasma membrane, ER, and MC membranes [<xref rid="B34-toxins-17-00073" ref-type="bibr">34</xref>,<xref rid="B35-toxins-17-00073" ref-type="bibr">35</xref>,<xref rid="B36-toxins-17-00073" ref-type="bibr">36</xref>,<xref rid="B37-toxins-17-00073" ref-type="bibr">37</xref>,<xref rid="B38-toxins-17-00073" ref-type="bibr">38</xref>]. Surprisingly, in this work, the Ca<sup>2+</sup><sub>e</sub>-independent release of stored Ca<sup>2+</sup> apparently had no effect on acetylcholine (ACh) exocytosis induced by &#x003b1;LTX [<xref rid="B31-toxins-17-00073" ref-type="bibr">31</xref>]. Thus, the role of Ca<sup>2+</sup><sub>cyt</sub> in the Ca<sup>2+</sup><sub>e</sub>-independent actions of &#x003b1;LTX remains controversial.</p><p>In this paper, we investigate the pore-dependent and receptor-dependent effects of &#x003b1;LTX on Ca<sup>2+</sup> release and Ca<sup>2+</sup> influx, and the role of Ca<sup>2+</sup><sub>cyt</sub> in &#x003b1;LTX-induced exocytosis. First, we demonstrate that Ca<sup>2+</sup><sub>cyt</sub> is required for &#x003b1;LTX-evoked secretion of ACh at mouse neuromuscular junctions (NMJ) in the absence of Ca<sup>2+</sup><sub>e</sub>. Then, using signaling and a non-signaling ADGRL1 construct, we show that the &#x003b1;LTX pore and ADGRL1 signaling contribute to Ca<sup>2+</sup> release, but target distinct Ca<sup>2+</sup> stores. We discuss the role of SOCCs and Ca<sup>2+</sup> extrusion in &#x003b1;LTX-induced elevation of Ca<sup>2+</sup><sub>cyt</sub> levels.</p></sec><sec sec-type="results" id="sec2-toxins-17-00073"><title>2. Results</title><sec sec-type="results" id="sec2dot1-toxins-17-00073"><title>2.1. &#x003b1;. LTX-Induced Release of Neurotransmitter Requires Intracellular Ca<sup>2+</sup></title><p>To study the role of intracellular Ca<sup>2+</sup> in the effect of &#x003b1;LTX on neurotransmitter release in the absence of Ca<sup>2+</sup><sub>e</sub>, we used mouse neuromuscular preparations that are known to respond to &#x003b1;LTX by massive exocytosis of synaptic vesicles both in the presence and absence of Ca<sup>2+</sup><sub>e</sub> [<xref rid="B11-toxins-17-00073" ref-type="bibr">11</xref>,<xref rid="B39-toxins-17-00073" ref-type="bibr">39</xref>,<xref rid="B40-toxins-17-00073" ref-type="bibr">40</xref>]. In a Ca<sup>2+</sup>-free medium, 0.1&#x02013;0.5 nM &#x003b1;LTX caused a dramatic (up to 1500-fold) increase in the frequency of miniature end-plate potentials (MEPPs), which correspond to &#x0201c;spontaneous&#x0201d; fusion events of synaptic vesicles containing ACh (<xref rid="toxins-17-00073-f001" ref-type="fig">Figure 1</xref>a,c,d). This rise in MEPP frequency was very gradual, only occurring 15&#x02013;30 min after &#x003b1;-LTX addition and continuing for 10&#x02013;70 min, with the frequency gradually decreasing until no MEPPs could be detected (<xref rid="toxins-17-00073-f001" ref-type="fig">Figure 1</xref>a). The average maximal MEPP frequency was 101 &#x000b1; 13 Hz (<italic toggle="yes">n</italic> = 18), and on average 43.8 &#x000d7; 10<sup>3</sup> &#x000b1; 15 &#x000d7; 10<sup>3</sup> vesicles were released from each continuously recorded nerve terminal (<italic toggle="yes">n</italic> = 10).</p><p>&#x003b1;LTX action was purely presynaptic because it only affected the frequency, but not the amplitude, of the MEPPs (<xref rid="toxins-17-00073-f001" ref-type="fig">Figure 1</xref>e). The recycling of synaptic vesicles in motor neuron terminals is inhibited in the absence of Ca<sup>2+</sup><sub>e</sub> [<xref rid="B41-toxins-17-00073" ref-type="bibr">41</xref>,<xref rid="B42-toxins-17-00073" ref-type="bibr">42</xref>], and indeed over time the toxin essentially depleted all releasable vesicles from nerve terminals, as evidenced by the failure of 2 mM Ca<sup>2+</sup><sub>e</sub> added after MEPP cessation to increase the frequency of exocytotic events (<xref rid="toxins-17-00073-f001" ref-type="fig">Figure 1</xref>a,c,d).</p><p>To probe the role of Ca<sup>2+</sup><sub>cyt</sub> in the &#x003b1;LTX-evoked exocytosis, we pretreated the preparation with a membranepermeable Ca<sup>2+</sup> chelator, BAPTA-AM, whose excess was later washed out from the bath (<xref rid="toxins-17-00073-f001" ref-type="fig">Figure 1</xref>f). As was observed under the microscope, a substantial amount of 200 &#x003bc;M BAPTA-AM precipitated out of solution, potentially leading to a decreased final concentration of BAPTA inside the cells.</p><p>To assess the level of cytosolic BAPTA achieved in this experiment, we used 20 mM KCl, which depolarizes the nerve terminal membrane, resulting in the opening of voltage-gated Ca<sup>2+</sup> channels, an influx of Ca<sup>2+</sup><sub>e</sub> and ACh exocytosis (<xref rid="app1-toxins-17-00073" ref-type="app">Figure S1a</xref>). If the cytosolic level of BAPTA exceeded 100 &#x003bc;M, it would have chelated most Ca<sup>2+</sup> entering nerve terminals and blocked exocytosis [<xref rid="B43-toxins-17-00073" ref-type="bibr">43</xref>]. In control NMJs, 20 mM KCl/2 mM Ca<sup>2+</sup><sub>e</sub> triggered a long train of high-frequency exocytosis, resulting in the eventual release of all vesicles. This suggests that KCl affected not only readily releasable vesicles, but also reserve-pool vesicles, and thus acted by increasing the general [Ca<sup>2+</sup>]<sub>cyt</sub>. Pretreatment of neuromuscular preparations with 200 &#x003bc;M BAPTA-AM significantly inhibited the exocytotic response to 20 mM KCl/2 mM Ca<sup>2+</sup> (<xref rid="app1-toxins-17-00073" ref-type="app">Figure S1b,c</xref>). However, KCl still induced a substantial increase in the frequency of MEPPs (<xref rid="app1-toxins-17-00073" ref-type="app">Figure S1c</xref>), indicating that the cytosolic concentration of BAPTA was not adequate to chelate all Ca<sup>2+</sup><sub>e</sub> entering nerve terminals.</p><p>We therefore conducted further experiments with 500 &#x003bc;M BAPTA-AM. Its addition initially caused some increase in MEPP frequency (<xref rid="toxins-17-00073-f001" ref-type="fig">Figure 1</xref>h). As the drug was hydrolyzed in the cytosol and regained the ability to chelate Ca<sup>2+</sup>, the average MEPP frequency fell to the level of the Ca<sup>2+</sup>-free control, where most cells showed no MEPPs, while few NMJs, located deeper in the muscle and thus less affected by BAPTA, appeared to show a higher MEPP frequency (<xref rid="toxins-17-00073-f001" ref-type="fig">Figure 1</xref>h). Subsequent application of &#x003b1;LTX caused a very small increase in MEPP frequency compared to its effect in non-BAPTA-treated terminals in the absence of Ca<sup>2+</sup><sub>e</sub> (<xref rid="toxins-17-00073-f001" ref-type="fig">Figure 1</xref>d,h). Again, the distribution of MEPP frequencies was clearly bimodal: most NMJs were completely &#x0201c;silent&#x0201d;, whereas the deeper terminals showed some exocytotic activity (<xref rid="toxins-17-00073-f001" ref-type="fig">Figure 1</xref>h). This inhibition of the toxin effect was not caused by the depletion of synaptic vesicles, because when 2 mM Ca<sup>2+</sup> was added to the medium at the end of recording, it entered the cells via &#x003b1;LTX pores and induced a strong increase in MEPP frequency, with all NMJs displaying an elevated activity. With the increased concentration of BAPTA-AM applied, the number of active synapses and their exocytotic activity significantly decreased. We interpret these results as demonstrating two important aspects: (i) when BAPTA-AM is used to load cells, its cytosolic concentration is often much lower than expected due to precipitation and is possibly insufficient to chelate all Ca<sup>2+</sup><sub>cyt</sub>; (ii) even in 0 Ca<sup>2+</sup><sub>e</sub>, &#x003b1;LTX strictly requires Ca<sup>2+</sup><sub>cyt</sub> to induce release of ACh from motor neuron terminals.</p></sec><sec sec-type="results" id="sec2dot2-toxins-17-00073"><title>2.2. &#x003b1;. LTX Induces Release of Ca<sup>2+</sup> from Intracellular Stores</title><p>The observation above suggested that &#x003b1;LTX might act by releasing Ca<sup>2+</sup> from some intracellular Ca<sup>2+</sup> stores. Given the fact that previous publications demonstrated the ability of thapsigargin (TG) to inhibit neurotransmitter exocytosis induced by a mutant toxin, LTX<sup>N4C</sup> [<xref rid="B20-toxins-17-00073" ref-type="bibr">20</xref>,<xref rid="B44-toxins-17-00073" ref-type="bibr">44</xref>], we tested whether TG, an inhibitor of the sarcoplasmic&#x02013;endoplasmic reticulum Ca<sup>2+</sup> ATPase (SERCA), could also inhibit the action of the wild-type &#x003b1;-LTX. Application of 10 &#x003bc;M TG to mouse NMJs in the absence of Ca<sup>2+</sup><sub>e</sub> (<xref rid="toxins-17-00073-f002" ref-type="fig">Figure 2</xref>a), induced a strong increase in the frequency of MEPPs that gradually subsided to a lower-than-control level within 10&#x02013;30 min (<xref rid="toxins-17-00073-f002" ref-type="fig">Figure 2</xref>a,b,f). The effect developed within 2&#x02013;5 min, with MEPP frequencies reaching ~50 Hz at the peak and 11.8 &#x000b1; 1.8 Hz on average. TG clearly acted both presynaptically (increasing MEPP frequency) and postsynaptically (raising the amplitude and duration of MEPPs) (<xref rid="toxins-17-00073-f002" ref-type="fig">Figure 2</xref>c&#x02013;e). Nevertheless, the presynaptic action of TG allowed us to assess the role of presynaptic Ca<sup>2+</sup> stores on the action of &#x003b1;LTX.</p><p>When &#x003b1;LTX was applied to neuromuscular preparations pretreated with TG for 30&#x02013;60 min, the effect of &#x003b1;LTX was greatly reduced but not completely blocked, and with time disappeared entirely (<xref rid="toxins-17-00073-f002" ref-type="fig">Figure 2</xref>a,f). Furthermore, 2 mM Ca<sup>2+</sup><sub>e</sub> added at the end of TG/&#x003b1;LTX activity was unable to stimulate any new exocytotic activity (<xref rid="toxins-17-00073-f001" ref-type="fig">Figure 1</xref>a,f). This suggests that (i) part of &#x003b1;LTX action induces Ca<sup>2+</sup> release from the ER that is sensitive to TG; however, (ii) the toxin also mobilizes Ca<sup>2+</sup> from some other stores that are not TG-sensitive; and (iii) in Ca<sup>2+</sup><sub>e</sub>-free conditions, both TG and &#x003b1;LTX block vesicle recycling and deplete the nerve terminals of all synaptic vesicles.</p><p>Thus, our experiments confirmed the critical role of stored Ca<sup>2+</sup> in the effects of wild-type &#x003b1;LTX in the absence of Ca<sup>2+</sup><sub>e</sub>.</p></sec><sec sec-type="results" id="sec2dot3-toxins-17-00073"><title>2.3. ADGRL1 Expression in NB2a Cells</title><p>To study the role of &#x003b1;LTX in [Ca<sup>2+</sup>]<sub>cyt</sub> regulation independently of ADGRL1 signaling, two constructs were expressed in a murine neuroblastoma cell line (NB2a). A full-size ADGRL1 (LPH) and a truncated ADGRL1 construct (&#x00394;LPH) were tagged with an extracellular V5 epitope for specific detection of expressed receptor (<xref rid="toxins-17-00073-f003" ref-type="fig">Figure 3</xref>a). In the signaling-incapable &#x00394;LPH, the N-terminal domain of ADGRL1 (for &#x003b1;LTX binding) was fused to the transmembrane domain of neurexin I, necessary for cell-surface expression of the ADGRL1 extracellular domain but unable to mediate G protein signaling.</p><p>&#x00394;LPH was expressed at a higher level (2.6 &#x000b1; 0.1 times) than LPH (<xref rid="toxins-17-00073-f003" ref-type="fig">Figure 3</xref>b). To see if this difference in expression resulted in &#x00394;LPH-expressing cells binding more &#x003b1;LTX than LPH-expressing cells, the cultures were incubated with an excessive concentration of &#x003b1;LTX (5 nM). &#x00394;LPH bound 2.3 &#x000b1; 0.4 times more &#x003b1;LTX than LPH (<xref rid="toxins-17-00073-f003" ref-type="fig">Figure 3</xref>c). These differences in expression level and &#x003b1;LTX interaction meant that subsequent [Ca<sup>2+</sup>]<sub>cyt</sub> recordings had to be analyzed relative to a minimum and maximum Ca<sup>2+</sup> indicator fluorescence.</p></sec><sec sec-type="results" id="sec2dot4-toxins-17-00073"><title>2.4. &#x003b1;. LTX Mobilizes Intracellular Ca<sup>2+</sup> Stores via Both Signaling and Non-Signaling Mechanisms</title><p>Mobilization of Ca<sup>2+</sup> from intracellular stores was detected using a membrane-permeable Ca<sup>2+</sup>-sensing dye, Fluo-4 AM, which was loaded into the ADGRL1-transfected or control neuroblastoma cells, where the dye was hydrolyzed and entrapped in the cytosol. As a control stimulant for Ca<sup>2+</sup> release we used TG. Application of this drug in 0 Ca<sup>2+</sup><sub>e</sub> allows one to clearly identify Ca<sup>2+</sup> release from the ER (<xref rid="toxins-17-00073-f004" ref-type="fig">Figure 4</xref>a, Ca<sup>2+</sup> release). Subsequent addition of 2 mM Ca<sup>2+</sup> to the medium leads to a transient peak of Ca<sup>2+</sup><sub>e</sub> influx that reveals the brief opening of SOCCs (<xref rid="toxins-17-00073-f004" ref-type="fig">Figure 4</xref>a, Ca<sup>2+</sup> peak). Finally, after the SOCCs close, a balance of Ca<sup>2+</sup> influx and extrusion is achieved, termed here &#x0201c;Ca<sup>2+</sup><sub>cyt</sub> equilibrium&#x0201d; (<xref rid="toxins-17-00073-f004" ref-type="fig">Figure 4</xref>a, Ca<sup>2+</sup> Eq).</p><p>To study the &#x003b1;LTX-induced effects on Ca<sup>2+</sup> release from intracellular stores and influx of Ca<sup>2+</sup><sub>e</sub>, NB2a cells (un-transfected or transfected with LPH) were loaded with Fluo-4 AM and stimulated in a three-step protocol. First, the cells were incubated in a Ca<sup>2+</sup>-free buffer. Then, &#x003b1;LTX and/or different pharmacological agents were added to detect their effects on Ca<sup>2+</sup> release. Subsequently, the cells were exposed to 2 mM Ca<sup>2+</sup><sub>e</sub> to reveal changes in Ca<sup>2+</sup> influx (<xref rid="toxins-17-00073-f004" ref-type="fig">Figure 4</xref>b). The changes in Fluo-4 fluorescence were continuously recorded as described in <xref rid="sec5-toxins-17-00073" ref-type="sec">Section 5</xref>. In the Ca<sup>2+</sup>-free medium, &#x003b1;LTX caused release of intracellular Ca<sup>2+</sup> only in ADGRL1-expressing cells (<xref rid="toxins-17-00073-f004" ref-type="fig">Figure 4</xref>b,c). This release occurred over several minutes, reaching a plateau which was apparently determined by the new equilibrium between [Ca<sup>2+</sup>]<sub>cyt</sub> and Ca<sup>2+</sup> extrusion mechanisms (<xref rid="toxins-17-00073-f004" ref-type="fig">Figure 4</xref>b). Upon the addition of Ca<sup>2+</sup><sub>e</sub>, there was an immediate large influx of Ca<sup>2+</sup>, which soon decayed to a relatively high, new level (Ca<sup>2+</sup> Eq). This transient opening of Ca<sup>2+</sup>-permeable channels was absent in control cells, while a small peak of Ca<sup>2+</sup> influx sometimes appeared in &#x003b1;LTX-treated un-transfected cells due to a low non-specific binding of &#x003b1;LTX to cell membranes (<xref rid="toxins-17-00073-f004" ref-type="fig">Figure 4</xref>b,d). Also, the Ca<sup>2+</sup> Eq in control cells was lower than in &#x003b1;LTX-treated cells (<xref rid="toxins-17-00073-f004" ref-type="fig">Figure 4</xref>b,e); this could involve several &#x003b1;LTX-mediated mechanisms: formation of toxin pores in the membrane, opening of some permanent Ca<sup>2+</sup> channels and/or perturbation of Ca<sup>2+</sup> extrusion.</p><p>In cells expressing &#x00394;LPH, &#x003b1;LTX-mediated Ca<sup>2+</sup> release in the absence of Ca<sup>2+</sup><sub>e</sub> was strongly attenuated (<xref rid="toxins-17-00073-f005" ref-type="fig">Figure 5</xref>a). Also, the rate of this release was 7.5-fold slower (<xref rid="toxins-17-00073-f005" ref-type="fig">Figure 5</xref>b), and [Ca<sup>2+</sup>]<sub>cyt</sub> continued to increase over the whole incubation period, whereas in LPH-expressing NB2a cells, a plateau of [Ca<sup>2+</sup>]<sub>cyt</sub> was reached within ~10 min. After 30 min of &#x003b1;LTX stimulation, Ca<sup>2+</sup> release in &#x00394;LPH cells was about half of that in LPH cells (<xref rid="toxins-17-00073-f005" ref-type="fig">Figure 5</xref>c). Upon the addition of Ca<sup>2+</sup><sub>e</sub>, &#x003b1;LTX failed to produce in &#x00394;LPH cells the distinct transient Ca<sup>2+</sup> peak that was seen in LPH cells (<xref rid="toxins-17-00073-f005" ref-type="fig">Figure 5</xref>d), demonstrating that ADGRL1 signaling leads to the opening of transient Ca<sup>2+</sup> channels in the cell membrane. After the decay of the transient Ca<sup>2+</sup> peak, [Ca<sup>2+</sup>]<sub>cyt</sub> remained high and did not differ significantly between the ADGRL1 constructs (<xref rid="toxins-17-00073-f005" ref-type="fig">Figure 5</xref>e), which indicates that the maintenance of a very high Ca<sup>2+</sup> Eq was due to &#x003b1;LTX only and did not involve any receptor-mediated signaling.</p><p>These results indicate that &#x003b1;LTX triggers Ca<sup>2+</sup> release by two mechanisms. First, &#x003b1;LTX binds to and activates ADGRL1. Next, it inserts itself into the cell membrane and forms a large, cation permeable pore. When acting via ADGRL1, &#x003b1;LTX activates both pore-mediated and receptor signaling-mediated Ca<sup>2+</sup> release mechanisms. When acting via &#x00394;LPH, &#x003b1;LTX only induces the pore-mediated mechanisms, and they lead to a slow Ca<sup>2+</sup> release based on a previously uncharacterized pathway.</p></sec><sec sec-type="results" id="sec2dot5-toxins-17-00073"><title>2.5. &#x003b1;. LTX Releases Ca<sup>2+</sup> from Non-ER Stores in Model Cells</title><p>As we showed above, the &#x003b1;LTX-triggered release of neurotransmitters from motor neurons in a Ca<sup>2+</sup><sub>e</sub>-free medium requires release of Ca<sup>2+</sup>, which at least in part comes from the ER (<xref rid="sec2dot2-toxins-17-00073" ref-type="sec">Section 2.2</xref>). Therefore, we investigated whether &#x003b1;LTX also triggers the release of Ca<sup>2+</sup> from the ER in our model cells expressing the two receptor variants. LPH- and &#x00394;LPH-expressing NB2a cells were treated with 0.3 &#x003bc;M TG in a Ca<sup>2+</sup>-free medium and then stimulated with &#x003b1;LTX (<xref rid="toxins-17-00073-f006" ref-type="fig">Figure 6</xref>).</p><p>In Ca<sup>2+</sup>-free media, TG induced the release of Ca<sup>2+</sup> from the ER in all cells, wild-type or transfected with any ADGRL1 construct (<xref rid="toxins-17-00073-f006" ref-type="fig">Figure 6</xref>a, black lines). This increase in Ca<sup>2+</sup><sub>cyt</sub> level developed quickly and returned to baseline levels within 10 min, as Ca<sup>2+</sup> was quickly extruded from the cytosol by various mechanisms (see <xref rid="sec3-toxins-17-00073" ref-type="sec">Section 3</xref>). The depletion of the ER of Ca<sup>2+</sup> caused the opening of the SOCCs in the plasma membrane, which was revealed as a clear transient peak of Ca<sup>2+</sup><sub>cyt</sub> upon the addition of Ca<sup>2+</sup> to the medium (<xref rid="toxins-17-00073-f006" ref-type="fig">Figure 6</xref>a,d).</p><p>Likewise, in Ca<sup>2+</sup>-free media, &#x003b1;LTX caused a release of Ca<sup>2+</sup> from some stores of LPH-expressing cells (<xref rid="toxins-17-00073-f006" ref-type="fig">Figure 6</xref>a, top, blue line). However, the &#x003b1;LTX-induced release was different from that evoked by TG: it developed more slowly (<xref rid="toxins-17-00073-f006" ref-type="fig">Figure 6</xref>c), and the level of Ca<sup>2+</sup><sub>cyt</sub> did not decrease due to Ca<sup>2+</sup> extrusion (<xref rid="toxins-17-00073-f006" ref-type="fig">Figure 6</xref>a). &#x003b1;LTX-evoked release was at least partially mediated by ADGRL1 signaling, because the &#x00394;LPH construct, despite binding more &#x003b1;LTX, only mediated a very slow increase in Ca<sup>2+</sup><sub>cyt</sub> that never reached the same level as in LPH-expressing cells (<xref rid="toxins-17-00073-f006" ref-type="fig">Figure 6</xref>a,c, blue). In addition, pretreatment of receptor-expressing cells with TG did not inhibit the &#x003b1;LTX-induced Ca<sup>2+</sup> release in either LPH- or &#x00394;LPH -expressing cells (<xref rid="toxins-17-00073-f006" ref-type="fig">Figure 6</xref>a,b,d), suggesting that in these model cells &#x003b1;LTX mobilizes the Ca<sup>2+</sup> stores that are different from the ER.</p><p>On the other hand, similar to TG, &#x003b1;LTX-induced depletion of a Ca<sup>2+</sup> store led to the opening of Ca<sup>2+</sup> channels in the plasma membrane, which were detected as a very large transient peak of Ca<sup>2+</sup> influx upon reintroduction of Ca<sup>2+</sup><sub>e</sub> (<xref rid="toxins-17-00073-f006" ref-type="fig">Figure 6</xref>a,d). This peak of SOCE was much larger than that induced by TG alone and was non-significantly increased by pretreating cells with TG (<xref rid="toxins-17-00073-f006" ref-type="fig">Figure 6</xref>a,d). Furthermore, the &#x003b1;LTX-evoked transient SOCE only appeared in cells expressing the signaling receptor construct (LPH) (<xref rid="toxins-17-00073-f006" ref-type="fig">Figure 6</xref>a,d, blue), while treating the &#x00394;LPH cells with both TG and &#x003b1;LTX only produced a Ca<sup>2+</sup> peak of the size evoked by TG alone (<xref rid="toxins-17-00073-f006" ref-type="fig">Figure 6</xref>d).</p><p>Finally, &#x003b1;LTX brought the ultimate equilibrium level of Ca<sup>2+</sup><sub>cyt</sub> to a very high value, much higher than in the case of TG treatment (<xref rid="toxins-17-00073-f006" ref-type="fig">Figure 6</xref>e). Because the &#x003b1;LTX-produced Ca<sup>2+</sup> Eq was similar in the cells expressing either the signaling or mutant receptor, it was likely caused by the presence of &#x003b1;LTX pores in the plasma membrane, which permitted Ca<sup>2+</sup> entry that was not easily balanced by Ca<sup>2+</sup> extrusion mechanisms.</p><p>These results suggest that TG-mediated inhibition of the SERCA and &#x003b1;LTX-induced ADGRL1-mediated signaling lead to the depletion of different Ca<sup>2+</sup> stores in our model cells. The depletion of the &#x003b1;LTX-sensitive stores leads to the opening of a larger pool of SOCCs that indeed includes the SOCCs activated by ER depletion. In addition, in both LPH- and &#x00394;LPH-expressing cells, &#x003b1;LTX actions similarly inhibit the mechanisms of Ca<sup>2+</sup> extrusion and therefore depend on the toxin pore only.</p></sec><sec sec-type="results" id="sec2dot6-toxins-17-00073"><title>2.6. &#x003b1;. LTX-Mediated Ca<sup>2+</sup> Release and Sustained Elevated [Ca<sup>2+</sup>]<sub>cyt</sub> Depends on Na<sup>+</sup><sub>e</sub></title><p>Na<sup>+</sup><sub>e</sub> has been shown to contribute to &#x003b1;LTX-mediated exocytosis [<xref rid="B45-toxins-17-00073" ref-type="bibr">45</xref>], so we used our model system to test whether Na<sup>+</sup> influx through &#x003b1;LTX pores actually contributes to [Ca<sup>2+</sup>]<sub>cyt</sub> regulation. To reveal the role of Na<sup>+</sup> influx we replaced Na<sup>+</sup><sub>e</sub> with N-methyl-D-glucamine (NMDG) (<xref rid="toxins-17-00073-f007" ref-type="fig">Figure 7</xref>a). In untreated control cells, removing Na<sup>+</sup><sub>e</sub> had no effect on constitutive Ca<sup>2+</sup> influx (<xref rid="toxins-17-00073-f007" ref-type="fig">Figure 7</xref>a,c,d). In the absence of Na<sup>+</sup><sub>e</sub>, &#x003b1;LTX-evoked Ca<sup>2+</sup> release in LPH-expressing cells was reduced by about 50% (although this change was not statistically significant), while in &#x00394;LPH-expressing cells it was abolished completely (<xref rid="toxins-17-00073-f007" ref-type="fig">Figure 7</xref>a,b, red lines). A similar effect was seen on the transient Ca<sup>2+</sup> influx peak: without Na<sup>+</sup><sub>e</sub>, the peak was reduced by 30% in LPH-cells but abolished in &#x00394;LPH-cells. These results clearly indicate that when receptor signaling is blocked and when &#x003b1;LTX solely acts by making membrane pores, both Ca<sup>2+</sup> release and Ca<sup>2+</sup> influx entirely depend on the influx of Na<sup>+</sup><sub>e</sub> through the toxin pores.</p><p>The Ca<sup>2+</sup> Eq level was reduced in the absence of Na<sup>+</sup> by the same extent as seen in LPH- and &#x00394;LPH-cells, but was not abolished (<xref rid="toxins-17-00073-f007" ref-type="fig">Figure 7</xref>d), revealing that the elevated equilibrium [Ca<sup>2+</sup>]<sub>cyt</sub> level was mediated by &#x003b1;LTX pores and not by ADGRL1 signaling, and that high equilibrium [Ca<sup>2+</sup>]<sub>cyt</sub> is sustained in the &#x003b1;LTX-treated cells due to the influx of Na<sup>+</sup> and, to a lesser extent, Ca<sup>2+</sup>. These results, together with the lack of decay of [Ca<sup>2+</sup>]<sub>cyt</sub> released from Ca<sup>2+</sup> stores, suggest that &#x003b1;LTX inhibits Ca<sup>2+</sup> extrusion mechanisms by increasing [Na<sup>+</sup>]<sub>cyt</sub>. High Na<sup>+</sup> is known to reverse the activity of NCX, and this may be the main mechanism of action of &#x003b1;LTX pores.</p></sec><sec sec-type="results" id="sec2dot7-toxins-17-00073"><title>2.7. &#x003b1;. LTX-Mediated [Ca<sup>2+</sup>]<sub>cyt</sub> Regulation Is Sensitive to SKF-96365</title><p>Our observations from <xref rid="sec2dot4-toxins-17-00073" ref-type="sec">Section 2.4</xref> and <xref rid="sec2dot5-toxins-17-00073" ref-type="sec">Section 2.5</xref> indicated that &#x003b1;LTX, by mobilizing Ca<sup>2+</sup> from intracellular stores, could induce SOCE. Therefore, we tested whether &#x003b1;LTX actions in LPH-expressing cells could be affected by the SOCE inhibitor SKF-96365 (SKF) [<xref rid="B46-toxins-17-00073" ref-type="bibr">46</xref>].</p><p>First, we found that, in the presence of Na<sup>+</sup>, SKF caused fast release of Ca<sup>2+</sup> from an intracellular store (<xref rid="toxins-17-00073-f008" ref-type="fig">Figure 8</xref>a, top, black curve). The resulting elevated [Ca<sup>2+</sup>]<sub>cyt</sub> did not decay with time and did not lead to an influx of Ca<sup>2+</sup> upon Ca<sup>2+</sup><sub>e</sub> add-back (<xref rid="toxins-17-00073-f008" ref-type="fig">Figure 8</xref>a,d, gray bars as indicated), indicating that SKF inhibited both Ca<sup>2+</sup> extrusion and SOCCs.</p><p>When &#x003b1;LTX was applied after SKF in the presence of Na<sup>+</sup>, it failed to release Ca<sup>2+</sup> above the effect of SKF (<xref rid="toxins-17-00073-f008" ref-type="fig">Figure 8</xref>a, top, red curve). Furthermore, the transient peak of Ca<sup>2+</sup> influx (that typically appears after &#x003b1;LTX action followed by re-addition of Ca<sup>2+</sup><sub>e</sub>) was totally prevented by SKF. These results suggest that SKF and &#x003b1;LTX act, possibly by different mechanisms, on the same intracellular Ca<sup>2+</sup> stores, but SKF blocks the transient SOCCs that normally respond to the depletion of this store by &#x003b1;LTX. This confirms our hypothesis that &#x003b1;LTX, by depleting intracellular Ca<sup>2+</sup> stores, induces SOCE.</p><p>Finally, comparing the final Ca<sup>2+</sup> Eq levels in cells treated with SKF and/or &#x003b1;LTX, we found that &#x003b1;LTX alone increased the final Ca<sup>2+</sup> equilibrium, while SKF did not. When applied together, SKF and &#x003b1;LTX substantially increased the level of Ca<sup>2+</sup> Eq compared to &#x003b1;LTX alone. This suggests that (i) as SOCCs are blocked by SKF, &#x003b1;LTX-induced opening of these channels does not contribute to the high final Ca<sup>2+</sup><sub>cyt</sub>; (ii) SKF further inhibits the extrusion of Ca<sup>2+</sup><sub>cyt</sub> that enters after &#x003b1;LTX action.</p><p>One of Ca<sup>2+</sup> extrusion pathways is the activity of NCX, which transports Ca<sup>2+</sup> from cytosol at the expense of transporting Na<sup>+</sup> into the cell. SKF is known to reverse NCX [<xref rid="B47-toxins-17-00073" ref-type="bibr">47</xref>], leading to the accumulation of Ca<sup>2+</sup> in the cytoplasm. As we demonstrate above, &#x003b1;LTX probably reverses NCX by over-loading the cytoplasm with Na<sup>+</sup>, whereas the effect of SKF on NCX should not depend on increased [Na<sup>+</sup>]<sub>cyt</sub>. As Ca<sup>2+</sup><sub>e</sub> was absent during the Ca<sup>2+</sup> release phase of our experiments, only the NCX present on the membrane of intracellular Ca<sup>2+</sup> stores (rather than on the plasma membrane) could lead to the accumulation of Ca<sup>2+</sup> in the cytosol as a result of NCX reversal by SKF. On the other hand, we showed above (<xref rid="toxins-17-00073-f007" ref-type="fig">Figure 7</xref>) that &#x003b1;LTX actions, at least in part, include the influx of Na<sup>+</sup> into the cytosol via the pores formed by &#x003b1;LTX in the plasma membrane, and this meant that elevation of Na<sup>+</sup><sub>cyt</sub> by &#x003b1;LTX&#x02014;rather than intracellular signaling&#x02014;could underlie the toxin-induced reversal of the NCX.</p><p>To test this possibility, we treated the LPH-cells with SKF and/or &#x003b1;LTX in the presence of NMDG (<xref rid="toxins-17-00073-f008" ref-type="fig">Figure 8</xref>a, bottom). &#x003b1;LTX alone still caused Ca<sup>2+</sup> release, albeit to a lesser extent (<xref rid="toxins-17-00073-f008" ref-type="fig">Figure 8</xref>c, black bar), and this action resulted in a typical SOCE (<xref rid="toxins-17-00073-f008" ref-type="fig">Figure 8</xref>a, bottom, blue curve), which was also decreased by ~30% (<xref rid="toxins-17-00073-f008" ref-type="fig">Figure 8</xref>d, black bars). This was consistent with a receptor-mediated signaling cascade leading to the depletion of a Ca<sup>2+</sup> store and the opening of SOCCs. SKF alone also caused a non-decreasing Ca<sup>2+</sup> release from intracellular stores, but the drug blocked any subsequent SOCE (<xref rid="toxins-17-00073-f008" ref-type="fig">Figure 8</xref>a, bottom, black curve). When &#x003b1;LTX was applied after SKF (<xref rid="toxins-17-00073-f008" ref-type="fig">Figure 8</xref>a, bottom, red curve), it failed to demonstrate both a statistically significant Ca<sup>2+</sup> release (<xref rid="toxins-17-00073-f008" ref-type="fig">Figure 8</xref>c, black bar) and any transient SOCC opening (<xref rid="toxins-17-00073-f008" ref-type="fig">Figure 8</xref>d, black bar). The ultimate equilibrium Ca<sup>2+</sup> level achieved by &#x003b1;LTX, alone or after SKF, was decreased by the removal of Na<sup>+</sup> (<xref rid="toxins-17-00073-f008" ref-type="fig">Figure 8</xref>e).</p><p>These results reveal that one major mechanism of &#x003b1;LTX action is Na<sup>+</sup> influx, which causes Ca<sup>2+</sup> to leave NCX-containing intracellular Ca<sup>2+</sup> stores and prevents Ca<sup>2+</sup> extrusion out of the cell. A second mechanism of toxin action involves ADGRL1-mediated signaling, which does not depend on Na<sup>+</sup> influx and induces Ca<sup>2+</sup> release from intracellular stores, followed by the opening of transient SOCCs.</p></sec></sec><sec sec-type="discussion" id="sec3-toxins-17-00073"><title>3. Discussion</title><p>Among the many different mechanisms of &#x003b1;LTX activity (detailed in the <xref rid="sec1-toxins-17-00073" ref-type="sec">Section 1</xref>), its effect on neurotransmitter release in the absence of Ca<sup>2+</sup><sub>e</sub> remains enigmatic: ADGRL1 signaling is reported to require Ca<sup>2+</sup><sub>e</sub> [<xref rid="B19-toxins-17-00073" ref-type="bibr">19</xref>,<xref rid="B20-toxins-17-00073" ref-type="bibr">20</xref>], while the role of the toxin pore in Ca<sup>2+</sup>-free media seems to be inconsistent with its known ability to pass Ca<sup>2+</sup><sub>e</sub> and thus activate exocytosis [<xref rid="B4-toxins-17-00073" ref-type="bibr">4</xref>]. Although Ca<sup>2+</sup>-independent effects of the &#x003b1;LTX pore have been reported, including Na<sup>+</sup><sub>e</sub> influx [<xref rid="B45-toxins-17-00073" ref-type="bibr">45</xref>,<xref rid="B48-toxins-17-00073" ref-type="bibr">48</xref>] and Ca<sup>2+</sup> release from intracellular stores [<xref rid="B31-toxins-17-00073" ref-type="bibr">31</xref>], these effects were thought to contribute little or not at all to the toxin action under Ca<sup>2+</sup>-free conditions. While the combination of multiple &#x003b1;LTX-induced mechanisms makes interpretation of its effects difficult, the use of &#x003b1;LTX under sufficiently discriminating conditions can shed light on novel synaptic mechanisms, as has been shown previously [<xref rid="B12-toxins-17-00073" ref-type="bibr">12</xref>]. In this paper, we used a non-signaling mutant of ADGRL1 to delineate some of &#x003b1;LTX&#x02019;s mechanisms.</p><p>Using mouse neuromuscular preparations, we found that the well-known &#x003b1;LTX effect&#x02014;a dramatic increase in the frequency of spontaneous exocytosis at the NMJ&#x02014;in fact strictly depends on the presence of Ca<sup>2+</sup><sub>cyt</sub>, which can only come from intracellular stores (<xref rid="toxins-17-00073-f001" ref-type="fig">Figure 1</xref>). Furthermore, TG, which releases Ca<sup>2+</sup> from the ER, causes a similar, if somewhat smaller, increase in MEPPs frequency and, by doing so, strongly inhibits the effect of &#x003b1;LTX (<xref rid="toxins-17-00073-f002" ref-type="fig">Figure 2</xref>). These results indicate that the enigmatic Ca<sup>2+</sup><sub>e</sub>-independent &#x003b1;LTX action is most likely based on the canonical mechanism of exocytosis that requires an increase in Ca<sup>2+</sup><sub>cyt</sub> to cause vesicle fusion with the plasma membrane. However, the exact pathways by which &#x003b1;LTX induces Ca<sup>2+</sup> release and the identity of the stores affected by the different &#x003b1;LTX actions remain to be uncovered.</p><p>To answer this question, we first compared the effects of &#x003b1;LTX and TG in neuroblastoma cells, used here as a model. In these and most other cells, TG depletes the ER of Ca<sup>2+</sup>, and the depletion of the Ca<sup>2+</sup> store stimulates the opening of SOCCs on the plasma membrane, which manifests itself as a transient SOCE upon reintroduction of Ca<sup>2+</sup> (<xref rid="toxins-17-00073-f009" ref-type="fig">Figure 9</xref>(ai)). We found that &#x003b1;LTX also releases Ca<sup>2+</sup> from intracellular stores in these cells but only if they are stably expressing &#x003b1;LTX receptors (<xref rid="toxins-17-00073-f004" ref-type="fig">Figure 4</xref>). To dissect the receptor-mediated and pore-mediated &#x003b1;LTX actions, we employed signaling (LPH) and non-signaling (&#x00394;LPH) receptor constructs (<xref rid="toxins-17-00073-f005" ref-type="fig">Figure 5</xref>). By subtracting the pore effects, which develop when &#x003b1;LTX binds &#x00394;LPH (<xref rid="toxins-17-00073-f009" ref-type="fig">Figure 9</xref>(aiv)), from the overall &#x003b1;LTX effects in LPH-expressing cells (<xref rid="toxins-17-00073-f009" ref-type="fig">Figure 9</xref>(aii)), we identified the receptor-mediated actions of &#x003b1;LTX (<xref rid="toxins-17-00073-f009" ref-type="fig">Figure 9</xref>(aiii)).</p><p>Acting via receptor signaling, &#x003b1;LTX causes a relatively slow release of Ca<sup>2+</sup> from intracellular stores (<xref rid="toxins-17-00073-f004" ref-type="fig">Figure 4</xref>; <xref rid="toxins-17-00073-f009" ref-type="fig">Figure 9</xref>(aiii)), which to a small extent depends on the presence of Na<sup>+</sup><sub>e</sub> (<xref rid="toxins-17-00073-f007" ref-type="fig">Figure 7</xref>). This effect is transient and is not attenuated by pretreatment with TG (<xref rid="toxins-17-00073-f006" ref-type="fig">Figure 6</xref>), indicating that, in these model cells, ADGRL1 signaling mobilizes a Ca<sup>2+</sup> store that is different from the ER, whose role is critical for &#x003b1;LTX effects on the NMJ. This highlights the limited applicability of neuroblastoma cells to studying presynaptic mechanisms. The depletion of this store also leads to the opening of a pool of SOCCs, revealed upon reintroduction of Ca<sup>2+</sup><sub>e</sub>, which is larger than the TG-sensitive pool of SOCCs (<xref rid="toxins-17-00073-f003" ref-type="fig">Figure 3</xref>, <xref rid="toxins-17-00073-f004" ref-type="fig">Figure 4</xref>, <xref rid="toxins-17-00073-f005" ref-type="fig">Figure 5</xref> and <xref rid="toxins-17-00073-f006" ref-type="fig">Figure 6</xref>; <xref rid="toxins-17-00073-f009" ref-type="fig">Figure 9</xref>(aiii)). This peak of Ca<sup>2+</sup> entry only occurs in cells possessing a signaling ADGRL1. The SOCC inhibitor SKF blocks these channels (<xref rid="toxins-17-00073-f008" ref-type="fig">Figure 8</xref>). The nature of the &#x003b1;LTX receptor-sensitive Ca<sup>2+</sup> store is not known but it could include MC, as previously suggested by Tsang et al. [<xref rid="B31-toxins-17-00073" ref-type="bibr">31</xref>]. Likewise, the ADGRL1 signaling mechanisms and the identity of the SOCCs sensitive to receptor signaling remain to be further investigated; such a study should be conducted in neurons, which constitute the natural target of &#x003b1;LTX, and employ &#x003b1;LTX mutants that lack the ability to form pores.</p><p>The &#x003b1;LTX pore action in the model cells appears to be more evident: our data indicate that a major function of the pore both in the absence of Ca<sup>2+</sup> and, to a large extent, in its presence, is to mediate Na<sup>+</sup> rather than Ca<sup>2+</sup> influx. Loading cells with Na<sup>+</sup> is known to reverse the direction of NCX, which is located in organelles (MC and ER) and cell membranes [<xref rid="B35-toxins-17-00073" ref-type="bibr">35</xref>,<xref rid="B36-toxins-17-00073" ref-type="bibr">36</xref>,<xref rid="B49-toxins-17-00073" ref-type="bibr">49</xref>,<xref rid="B50-toxins-17-00073" ref-type="bibr">50</xref>]. NCX reversal leads to both the leak of Ca<sup>2+</sup> from organelles and the inhibition of its extrusion from the cytosol, where it slowly accumulates with time in contrast to TG-induced Ca<sup>2+</sup><sub>cyt</sub> (<xref rid="toxins-17-00073-f006" ref-type="fig">Figure 6</xref> and <xref rid="toxins-17-00073-f007" ref-type="fig">Figure 7</xref>; <xref rid="toxins-17-00073-f009" ref-type="fig">Figure 9</xref>(ai)). Our studies with SKF support this, because this SOCE inhibitor [<xref rid="B24-toxins-17-00073" ref-type="bibr">24</xref>,<xref rid="B46-toxins-17-00073" ref-type="bibr">46</xref>] also reverses NCX [<xref rid="B47-toxins-17-00073" ref-type="bibr">47</xref>]. Upon Ca<sup>2+</sup><sub>e</sub> reintroduction, the &#x003b1;LTX pore elicits an increase in Ca<sup>2+</sup><sub>cyt</sub>, which lacks the transient peak of Ca<sup>2+</sup> influx and is maintained due to (i) the influx of Ca<sup>2+</sup> and Na<sup>+</sup> through the &#x003b1;LTX pores and (ii) the inhibition of Ca<sup>2+</sup><sub>cyt</sub> extrusion by high Na<sup>+</sup><sub>cyt</sub>.</p><p>Previously, Tsang et al. [<xref rid="B31-toxins-17-00073" ref-type="bibr">31</xref>] found that in 0 Ca<sup>2+</sup><sub>e</sub>, BAPTA-AM blocked the &#x003b1;LTX-induced increase in [Ca<sup>2+</sup>]<sub>cyt</sub> in frog NMJs but did not inhibit the effect of &#x003b1;LTX on the frequency of MEPPs. These results are in disagreement with our observations (<xref rid="sec2dot1-toxins-17-00073" ref-type="sec">Section 2.1</xref>), which irrefutably show an inhibitory effect of BAPTA on the &#x003b1;LTX-evoked release of ACh at mouse NMJs. One possible reason could be the difference between the frog and mouse nerve terminals: frog NMJs are much larger and contain many times more vesicles and other intracellular organelles than mouse NMJs. It is possible that intracellular BAPTA could block the global Ca<sup>2+</sup><sub>e</sub> build-up in the large frog NMJs but still allow Ca<sup>2+</sup> action near the vesicle release sites, as suggested previously [<xref rid="B48-toxins-17-00073" ref-type="bibr">48</xref>]. Another possible reason for the disagreement between their optical and electrophysiological recordings could be that BAPTA-AM precipitation, as we describe above, could (i) produce an insufficient concentration of intrasynaptic BAPTA, especially in the NMJs located deeper in the muscle and (ii) optically obscure the Ca<sup>2+</sup> fluorescence signal. Indeed, we see that BAPTA-AM produces high turbidity in bath solution and while it blocks all exocytosis in superficial NMJs, it is ineffective in deeper synapses that respond to &#x003b1;LTX (<xref rid="toxins-17-00073-f001" ref-type="fig">Figure 1</xref>).</p><p>Also, Tsang et al. [<xref rid="B31-toxins-17-00073" ref-type="bibr">31</xref>] observed very little effect of TG on spontaneous MEPP frequency and no effect on the excitatory action of &#x003b1;LTX. This, to some extent, agrees with our data: while ER depletion inhibits, albeit incompletely, the &#x003b1;LTX-induced exocytosis in mouse NMJs (<xref rid="toxins-17-00073-f002" ref-type="fig">Figure 2</xref>), it does not affect the &#x003b1;LTX-induced Ca<sup>2+</sup> release in model neuroblastoma cells (<xref rid="toxins-17-00073-f006" ref-type="fig">Figure 6</xref>). On the other hand, TG itself induces a very large increase in MEPP frequency in mouse NMJs at 0 Ca<sup>2+</sup><sub>e</sub> (<xref rid="toxins-17-00073-f002" ref-type="fig">Figure 2</xref>). Again, the likely reason for this discrepancy is the architecture of the cells studied: both frog NMJs and ADGRL1-transfected cells have a much larger volume than mouse NMJs. The lack of TG effect on the &#x003b1;LTX action in these large cells could be due to the large buffering capability of their MC [<xref rid="B50-toxins-17-00073" ref-type="bibr">50</xref>] and to the distinct distribution of organelles within the cell. Thus, the bulk of Ca<sup>2+</sup> that is indirectly and relatively slowly released from the ER by TG or by ADGRL1-mediated signaling could be taken up by MC in neuroblastoma cells and frog NMJs but not in smaller mouse NMJs. Also, it is important to stress that our results clearly demonstrate that, at least in the model cells, there are two distinct sources of Ca<sup>2+</sup> which are depleted by different mechanisms (<xref rid="sec2dot5-toxins-17-00073" ref-type="sec">Section 2.5</xref>). The nature of these stores awaits proper elucidation.</p><p>As a final note, our observations underscore the importance of selecting adequately reduced systems to investigate complex biological phenomena, such as the complex effects of a toxin on an equally complex mechanism of neurotransmitter exocytosis. Further work will be required to dissect the receptor-mediated actions of &#x003b1;LTX, identify the SOCCs involved and delineate the role of different ADGRL homologs in the toxin&#x02019;s effect.</p></sec><sec sec-type="conclusions" id="sec4-toxins-17-00073"><title>4. Conclusions</title><p>Wild-type &#x003b1;LTX strictly requires Ca<sup>2+</sup><sub>cyt</sub> to produce massive neurotransmitter exocytosis in the absence of Ca<sup>2+</sup><sub>e</sub>. Under these conditions, the toxin induces the depletion of distinct Ca<sup>2+</sup> stores in different cells and thus elevates [Ca<sup>2+</sup>]<sub>cyt</sub> by at least two separate mechanisms: receptor signaling and the influx of Na<sup>+</sup> through &#x003b1;LTX pores. ADGRL1-mediated depletion of the ER and/or other stores activates transient Ca<sup>2+</sup> channels (SOCCs) that are independent of the &#x003b1;LTX pore. The toxin pore mediates an increase in [Na<sup>+</sup>]<sub>cyt</sub> that causes NCX reversal and leads to release of Ca<sup>2+</sup> from the ER and/or MC and inhibits Ca<sup>2+</sup><sub>cyt</sub> extrusion, providing the source of Ca<sup>2+</sup><sub>cyt</sub> for exocytosis via classical Ca<sup>2+</sup>-induced membrane fusion.</p></sec><sec id="sec5-toxins-17-00073"><title>5. Materials and Methods</title><sec id="sec5dot1-toxins-17-00073"><title>5.1. Materials</title><p>All chemicals and reagents were purchased from Sigma-Aldrich (Merck Life Science UK Limited, Gillingham, Dorset, UK) unless otherwise stated. The following antibodies were used for Western blotting: rabbit anti-V5 polyclonal antibody, rabbit anti-&#x003b1;LTX serum (produced in the lab), and IRDye<sup>&#x000ae;</sup> 800CW goat anti-rabbit IgG secondary antibody (LI-COR Ltd. United Kingdom, Cambridge, UK).</p><p>&#x003b1;LTX was purified from lyophilized venom of black widow spiders, <italic toggle="yes">Latrodectus lugubris</italic>, as described previously [<xref rid="B51-toxins-17-00073" ref-type="bibr">51</xref>]. Toxin homogeneity was verified by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and amino acid analysis. The latter method was also employed to determine protein concentration in a reference sample of &#x003b1;LTX, which was subsequently used in conjunction with SDS-PAGE, Coomassie R250 staining and computer-assisted densitometry to quantify all other toxin preparations. To demonstrate the specific action of the purified natural toxin, some experiments were performed using 0.5 nM recombinant &#x003b1;LTX expressed in a baculovirus system and purified by affinity chromatography [<xref rid="B19-toxins-17-00073" ref-type="bibr">19</xref>,<xref rid="B52-toxins-17-00073" ref-type="bibr">52</xref>], yielding identical results.</p><p>A 50 mM stock solution of BAPTA-AM (Thermo-Fisher Scientific, Oxford, UK, Life Technologies Limited, Paisley, UK) was prepared in DMSO, then diluted with a physiological buffer containing 0.1% Pluronic F-127 (Thermo-Fisher Scientific, Oxford, UK) to obtain a 5 mM secondary stock and sonicated.</p></sec><sec id="sec5dot2-toxins-17-00073"><title>5.2. Neurotransmitter Release</title><p>Spontaneous synaptic activity at mouse NMJs (in the form of MEPPs) was recorded using <italic toggle="yes">flexor digitorum brevis</italic> neuromuscular preparations dissected from hind paws of 3&#x02013;6 weeks-old male mice, pinned inside Petri dishes coated with Sylgard (Dow Silicones UK Ltd., Barry, Wales, UK) and containing preformed perfusion chambers. The preparation was observed under a high-power binocular microscope with dark-field illumination and perfused with oxygenated physiological buffer containing (in mM): NaCl, 137; KCl, 5; MgCl<sub>2</sub>, 1; EGTA, 0.2; glucose, 5.6; HEPES, 10; pH 7.5). When required, the perfusion was stopped, and 0.5 nM &#x003b1;LTX, 200&#x02013;500 &#x003bc;M BAPTA-AM, 10 &#x003bc;M TG, 20 mM KCl and/or 2.2 mM CaCl<sub>2</sub> was added (final concentrations). Changes in the postsynaptic membrane potential (<italic toggle="yes">V</italic>m) were detected using sharp glass microelectrodes filled with 5 M ammonium acetate (impedance ~70 MOhm), pre-amplified using an Axoclamp 2B amplifier (Molecular Devices, LLC, San Jose, CA, USA) in the current clamp mode, amplified and filtered using a differential amplifier with a high-frequency filter (LPF202A, Warner Instruments) and a harmonic frequency quencher (HumBug, Digitimer Ltd., Welwyn Garden City, Hertfordshire, UK), and then digitized with a Digidata 1322A digitizer controlled by the AxoScope 10.7 software (Molecular Devices). The traces were analyzed using the Mini Analysis software Version 6.0.7 (Synaptosoft Inc., Decatur, GA, USA).</p></sec><sec id="sec5dot3-toxins-17-00073"><title>5.3. Cell Culture</title><p>NB2a cell lines stably transfected with LPH, and &#x00394;LPH constructs were kindly provided by K. E. Volynski. The cells were cultured in complete medium (Dulbecco-modified Eagle&#x02019;s medium containing 0.5 mM GlutaMAX<sup>TM</sup> and 10% fetal bovine serum). Cells were kept at 37 &#x000b0;C in a humidified atmosphere consisting of 5% CO<sub>2</sub>. Cells were allowed to grow to 80% confluency before passaging, and cells were detached using 0.05% Trypsin-EDTA. Differentiation was induced 24 h after plating cells by replacing complete medium with Neurobasal-A medium supplemented with 2% B-27 and 0.5 mM GlutaMAX<sup>TM</sup>, and experiments were performed 24&#x02013;48 h after differentiation was induced.</p></sec><sec id="sec5dot4-toxins-17-00073"><title>5.4. ADGRL1 Construct Expression Assay</title><p>Cells seeded in T25 tissue culture flasks were differentiated for 40&#x02013;44 h and then detached by tapping the flask. Cells were resuspended in PBS containing 1 mg/mL BSA at a concentration of 5 &#x000d7; 106 cells per mL. Cells were centrifuged and lysed in PBS containing 1% Triton X-100 for 30 min, on ice. A loading buffer (final concentrations were: 0.0625 M Tris (pH 6.8), 2% SDS, 10% glycerol, 0.1 M DTT, 0.01% bromophenol blue) was added to samples, vortexed, heated at 50 &#x000b0;C for 20 min and stored at &#x02013;20 &#x000b0;C.</p></sec><sec id="sec5dot5-toxins-17-00073"><title>5.5. &#x003b1;. LTX Binding Assay</title><p>Cells seeded in T25 flasks were differentiated for 40&#x02013;44 h and then detached by tapping the flask. Cells were resuspended in PBS containing 1 mg/mL BSA at a concentration of 5 &#x000d7; 10<sup>6</sup> cells per mL and transferred to 1.5 mL tubes. Cells were exposed to 5 nM &#x003b1;LTX for 10 min on ice, then spun down at 40&#x000d7; <italic toggle="yes">g</italic> for 2 min. The supernatant, which contained unbound &#x003b1;LTX, was transferred to fresh tubes. The cell pellet was washed briefly with PBS, spun down for 10 s, and then lysed in PBS containing 1% Triton X-100 for 30 min on ice. Cells were spun down at 12,000&#x000d7; <italic toggle="yes">g</italic> for 20 min at 4 &#x000b0;C and the supernatant, which contained &#x003b1;LTX bound to ADGRL1, was transferred to fresh tubes. Loading buffer was added to samples, vortexed, heated at 50 &#x000b0;C for 20 min and stored at &#x02212;20 &#x000b0;C.</p></sec><sec id="sec5dot6-toxins-17-00073"><title>5.6. Western Blotting</title><p>Whole-cell lysates and supernatants were separated by SDS-PAGE. Polyacrylamide gels (8%) were prepared, using 40% ProtoGel, ProtoGel Stacking Buffer, 4X ProtoGel Resolving Buffer, TEMED and ammonium persulfate (National Diagnostic, Atlanta, GA, USA)according to manufacturer&#x02019;s protocol. The inner and outer chambers of the gel tank were filled with TRIS/Glycine/SDS running buffer (National Diagnostics, Atlanta, GA, USA). The samples (30 &#x003bc;L) and molecular weight markers (PageRuler, Thermo-Fisher Scientific, Oxford, UK) were separated by running 120 V through the gel for up to 1.5 h. Proteins were electrophoretically transferred onto polyvinylidene fluoride membranes (0.45 &#x003bc;m pore) in TRIS/Glycine transfer buffer containing 20% methanol (National Diagnostics), at a constant current of 180 mA for 1 h.</p><p>Membranes blocked in 5% non-fat milk dissolved in Tris-buffered saline with Tween-20 (TBST, National Diagnostics) for 1 h at RT and stained using respective primary antibodies (1:1000 dilution) and fluorescent secondary antibody (1:2000 dilution). Fluorescent detection was performed using Odyssey imaging system (LI-COR Ltd. United Kingdom) and protein bands were analyzed in ImageJ (version 1.45m; National Institutes of Health, Madison, WI, USA; doi:10.1038/nmeth.2089).</p></sec><sec id="sec5dot7-toxins-17-00073"><title>5.7. Ca<sup>2+</sup><sub>cyt</sub> Recordings</title><p>NB2a cells were seeded onto black-walled, clear-bottomed 96-well plates (VWR International, LLC, Radnor, PA, USA) and differentiated for 24&#x02013;48 h. Cells were loaded with the cell-permeable Ca<sup>2+</sup> indicator Fluo-4-AM (Thermo-Fisher Scientific, Oxford, UK, Life Technologies Limited, Paisley, UK) according to manufacturer&#x02019;s protocol, and fluorescence was detected on a Fluoroskan Ascent FL microplate fluorometer (Labsystems Diagnostics Oy, Helsinki, Finland) with 495/538 nm excitation/emission filters. Fluorescence was measured in multiple replicates every 15 s with 100 ms integration time. Cells were equilibrated in Recording buffer (in mM: NaCl, 145; KCl, 5.6; glucose, 5.6; MgCl<sub>2</sub>, 1; HEPES, 15; BSA, 0.5 mg/mL; sulfinpyrazone, 0.25; pH, 7.4). The experimental protocols are described in the Results. &#x003b1;LTX and pharmacological inhibitors (TG, SKF) were added to individual wells by pipette during a brief pause in recording, while buffer containing Ca<sup>2+</sup> (to achieve a final concentration of 2 mM) was added automatically via an internal Fluoroskan dispenser. Experiments were usually performed in triplicate and repeated independently at least three times.</p><p>As Fluo-4 is a single-wavelength, non-ratiometric indicator, its fluorescence had to be compensated for the variance in the number of cells scanned in each well. Therefore, Equation 1 was used to normalize fluorescence intensity (<italic toggle="yes">F</italic>) to an average initial baseline value (<italic toggle="yes">F<sub>min</sub></italic>) and a maximal value (<italic toggle="yes">F<sub>max</sub></italic>), obtained by permeabilizing cells with 1% Triton X-100 at the end of each experiment.<disp-formula id="FD1-toxins-17-00073"><label>(1)</label><mml:math id="mm1" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mo>&#x02206;</mml:mo><mml:msub><mml:mrow><mml:mi>F</mml:mi></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mstyle scriptlevel="0" displaystyle="true"><mml:mfrac><mml:mrow><mml:mi>F</mml:mi><mml:mo>&#x02212;</mml:mo><mml:msub><mml:mrow><mml:mi>F</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>F</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:msub><mml:mo>&#x02212;</mml:mo><mml:msub><mml:mrow><mml:mi>F</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac></mml:mstyle></mml:mrow></mml:mrow></mml:math></disp-formula></p><p>Release of Ca<sup>2+</sup> from intracellular stores was measured as the increase in &#x02206;<italic toggle="yes">F<sub>n</sub></italic> from the baseline. Ca<sup>2+</sup><sub>cyt</sub> equilibrium in the presence of Ca<sup>2+</sup><sub>e</sub> (Ca<sup>2+</sup> Eq) was measured as &#x02206;<italic toggle="yes">F<sub>n</sub></italic> amplitude and the transient Ca<sup>2+</sup> peak was measured as the &#x02206;<italic toggle="yes">F<sub>n</sub></italic> amplitude above Ca<sup>2+</sup> Eq.</p></sec><sec id="sec5dot8-toxins-17-00073"><title>5.8. Statistical Analysis</title><p>Statistical analysis was performed in Prism 6 software (GraphPad Software, Boston, MA, USA). Unless otherwise stated, two-tailed Student&#x02019;s <italic toggle="yes">t</italic>-test was performed for comparisons between two groups, or one-way analysis of variance (ANOVA) was used for three or more groups with Bonferroni correction. Statistical significance was accepted at <italic toggle="yes">p</italic> &#x0003c; 0.05. The level of significance was also indicated on graphs (<italic toggle="yes">p</italic> &#x0003c; 0.05:*, <italic toggle="yes">p</italic> &#x0003c; 0.01:**, <italic toggle="yes">p</italic> &#x0003c; 0.001:***, <italic toggle="yes">p</italic> &#x0003c; 0.0001:****).</p></sec></sec></body><back><ack><title>Acknowledgments</title><p>The authors are grateful to M.A. Rahman for kindly providing &#x003b1;LTX, to K.E Volynski for kindly providing stably transfected NB2a cell lines and to V. V. Sumbayev for help with the organization of work.</p></ack><fn-group><fn><p><bold>Disclaimer/Publisher&#x02019;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><app-group><app id="app1-toxins-17-00073"><title>Supplementary Materials</title><p>The following supporting information can be downloaded at: <uri xlink:href="https://www.mdpi.com/article/10.3390/toxins17020073/s1">https://www.mdpi.com/article/10.3390/toxins17020073/s1</uri>, Figure S1: 200 &#x003bc;M BAPTA-AM does not produce a sufficient cytosolic level of BAPTA to chelate all Ca<sup>2+</sup><sub>e</sub> entering via voltage-gated Ca<sup>2+</sup> channels. (<bold>a</bold>) An example of the effect of 20 mM KCl on the frequency of spontaneous MEPPs in mouse neuromuscular preparations in the presence of 2 mM Ca<sup>2+</sup><sub>e</sub>, continuously recorded from an individual muscle fiber. (<bold>b</bold>) Top, the experimental protocol: initial incubation in a Ca<sup>2+</sup>-free buffer; treatment with 200 &#x003bc;M BAPTA-AM; an extended washing step with a Ca<sup>2+</sup>-free buffer; addition of 20 mM KCl/2 mM Ca<sup>2+</sup><sub>e</sub>. Bottom, changes in the frequency of MEPPs under the experimental conditions indicated above. (<bold>c</bold>,<bold>d</bold>) Mean MEPP frequencies and amplitudes during respective experimental stages. The bars are the means &#x000b1; <italic toggle="yes">SEM</italic>; the bar colors correspond to protocol phases; asterisks show statistical significance compared to Ca<sup>2+</sup><sub>e</sub>-free control, unless indicated by lines; *, <italic toggle="yes">p</italic> &#x0003c; 0.05; **, <italic toggle="yes">p</italic> &#x0003c; 0.01; ***, <italic toggle="yes">p</italic> &#x0003c; 0.001; <italic toggle="yes">NS</italic>, non-significant; for each condition shown the <italic toggle="yes">n</italic> = 6&#x02013;15 individual muscle fibers from 3 independent neuromuscular preparations.</p><supplementary-material id="toxins-17-00073-s001" position="float" content-type="local-data"><media xlink:href="toxins-17-00073-s001.zip"/></supplementary-material></app></app-group><notes><title>Author Contributions</title><p>Conceptualization, Y.A.U.; methodology, Y.A.U. and J.K.B.; validation, Y.A.U. and J.K.B.; formal analysis, J.K.B., Q.S.I., O.B., S.A.T., E.P. and Y.A.U.; investigation, J.K.B., Q.S.I., O.B. and E.P.; resources, Y.A.U.; data curation, Y.A.U., J.K.B. and E.P.; writing&#x02014;original draft preparation, J.K.B.; writing&#x02014;review and editing, Y.A.U., J.K.B., Q.S.I., O.B. and E.P.; visualization, J.K.B. and Y.A.U.; supervision, Y.A.U.; project administration, Y.A.U.; funding acquisition, Y.A.U. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Institutional Review Board Statement</title><p>The animal study protocol, which did not involve any regulated procedures, was approved by the University of Kent Animal Welfare Research Ethics Review Board (October 2017).</p></notes><notes><title>Informed Consent Statement</title><p>Not applicable.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>The data supporting reported results can be found in the following publicly archived datasets: <uri xlink:href="https://figshare.com">https://figshare.com</uri>; 10.6084/m9.figshare.28138064.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>Author Evelina Petitto was employed by Ashfield MedComms, The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-toxins-17-00073"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Silva</surname><given-names>J.-P.</given-names></name>
<name><surname>Suckling</surname><given-names>J.</given-names></name>
<name><surname>Ushkaryov</surname><given-names>Y.</given-names></name>
</person-group><article-title>Penelope&#x02019;s Web: Using &#x003b1;-Latrotoxin to Untangle the Mysteries of Exocytosis</article-title><source>J. Neurochem.</source><year>2009</year><volume>111</volume><fpage>275</fpage><lpage>290</lpage><pub-id pub-id-type="doi">10.1111/j.1471-4159.2009.06329.x</pub-id><pub-id pub-id-type="pmid">19682210</pub-id>
</element-citation></ref><ref id="B2-toxins-17-00073"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yan</surname><given-names>S.</given-names></name>
<name><surname>Wang</surname><given-names>X.</given-names></name>
</person-group><article-title>Recent Advances in Research on Widow Spider Venoms and Toxins</article-title><source>Toxins</source><year>2015</year><volume>7</volume><fpage>5055</fpage><lpage>5067</lpage><pub-id pub-id-type="doi">10.3390/toxins7124862</pub-id><pub-id pub-id-type="pmid">26633495</pub-id>
</element-citation></ref><ref id="B3-toxins-17-00073"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Longenecker</surname><given-names>H.E.</given-names><suffix>Jr.</suffix></name>
<name><surname>Hurlbut</surname><given-names>W.P.</given-names></name>
<name><surname>Mauro</surname><given-names>A.</given-names></name>
<name><surname>Clark</surname><given-names>A.W.</given-names></name>
</person-group><article-title>Effects of Black Widow Spider Venom on the Frog Neuromuscular Junction</article-title><source>Nature</source><year>1970</year><volume>225</volume><fpage>701</fpage><lpage>703</lpage><pub-id pub-id-type="doi">10.1038/225701a0</pub-id><pub-id pub-id-type="pmid">4312878</pub-id>
</element-citation></ref><ref id="B4-toxins-17-00073"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Finkelstein</surname><given-names>A.</given-names></name>
<name><surname>Rubin</surname><given-names>L.L.</given-names></name>
<name><surname>Tzeng</surname><given-names>M.C.</given-names></name>
</person-group><article-title>Black Widow Spider Venom: Effect of Purified Toxin on Lipid Bilayer Membranes</article-title><source>Science</source><year>1976</year><volume>193</volume><fpage>1009</fpage><lpage>1011</lpage><pub-id pub-id-type="doi">10.1126/science.948756</pub-id><pub-id pub-id-type="pmid">948756</pub-id>
</element-citation></ref><ref id="B5-toxins-17-00073"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rosenthal</surname><given-names>L.</given-names></name>
<name><surname>Meldolesi</surname><given-names>J.</given-names></name>
</person-group><article-title>&#x003b1;-Latrotoxin and Related Toxins</article-title><source>Pharmacol. Ther.</source><year>1989</year><volume>42</volume><fpage>115</fpage><lpage>134</lpage><pub-id pub-id-type="doi">10.1016/0163-7258(89)90024-7</pub-id><pub-id pub-id-type="pmid">2657806</pub-id>
</element-citation></ref><ref id="B6-toxins-17-00073"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Clark</surname><given-names>A.W.</given-names></name>
<name><surname>Mauro</surname><given-names>A.</given-names></name>
<name><surname>Longenecker</surname><given-names>H.E.</given-names></name>
<name><surname>Hurlbut</surname><given-names>W.P.</given-names></name>
</person-group><article-title>Effects of Black Widow Spider Venom on the Frog Neuromuscular Junction. Effects on the Fine Structure of the Frog Neuromuscular Junction</article-title><source>Nature</source><year>1970</year><volume>225</volume><fpage>703</fpage><lpage>705</lpage><pub-id pub-id-type="doi">10.1038/225703a0</pub-id><pub-id pub-id-type="pmid">4312879</pub-id>
</element-citation></ref><ref id="B7-toxins-17-00073"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ushkaryov</surname><given-names>Y.A.</given-names></name>
<name><surname>Petrenko</surname><given-names>A.G.</given-names></name>
<name><surname>Geppert</surname><given-names>M.</given-names></name>
<name><surname>Sudhof</surname><given-names>T.C.</given-names></name>
</person-group><article-title>Neurexins: Synaptic Cell Surface Proteins Related to the &#x003b1;-Latrotoxin Receptor and Laminin</article-title><source>Science</source><year>1992</year><volume>257</volume><fpage>50</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.1126/science.1621094</pub-id><pub-id pub-id-type="pmid">1621094</pub-id>
</element-citation></ref><ref id="B8-toxins-17-00073"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Davletov</surname><given-names>B.A.</given-names></name>
<name><surname>Shamotienko</surname><given-names>O.G.</given-names></name>
<name><surname>Lelianova</surname><given-names>V.G.</given-names></name>
<name><surname>Grishin</surname><given-names>E.V.</given-names></name>
<name><surname>Ushkaryov</surname><given-names>Y.A.</given-names></name>
</person-group><article-title>Isolation and Biochemical Characterization of a Ca<sup>2+</sup>-Independent &#x003b1;-Latrotoxin-Binding Protein</article-title><source>J. Biol. Chem.</source><year>1996</year><volume>271</volume><fpage>23239</fpage><lpage>23245</lpage><pub-id pub-id-type="doi">10.1074/jbc.271.38.23239</pub-id><pub-id pub-id-type="pmid">8798521</pub-id>
</element-citation></ref><ref id="B9-toxins-17-00073"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Krasnoperov</surname><given-names>V.G.</given-names></name>
<name><surname>Bittner</surname><given-names>M.A.</given-names></name>
<name><surname>Beavis</surname><given-names>R.</given-names></name>
<name><surname>Kuang</surname><given-names>Y.</given-names></name>
<name><surname>Salnikow</surname><given-names>K.V.</given-names></name>
<name><surname>Chepurny</surname><given-names>O.G.</given-names></name>
<name><surname>Little</surname><given-names>A.R.</given-names></name>
<name><surname>Plotnikov</surname><given-names>A.N.</given-names></name>
<name><surname>Wu</surname><given-names>D.</given-names></name>
<name><surname>Holz</surname><given-names>R.W.</given-names></name>
<etal/>
</person-group><article-title>&#x003b1;-Latrotoxin Stimulates Exocytosis by the Interaction with a Neuronal G-Protein-Coupled Receptor</article-title><source>Neuron</source><year>1997</year><volume>18</volume><fpage>925</fpage><lpage>937</lpage><pub-id pub-id-type="doi">10.1016/S0896-6273(00)80332-3</pub-id><pub-id pub-id-type="pmid">9208860</pub-id>
</element-citation></ref><ref id="B10-toxins-17-00073"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hamann</surname><given-names>J.</given-names></name>
<name><surname>Aust</surname><given-names>G.</given-names></name>
<name><surname>Arac</surname><given-names>D.</given-names></name>
<name><surname>Engel</surname><given-names>F.B.</given-names></name>
<name><surname>Formstone</surname><given-names>C.</given-names></name>
<name><surname>Fredriksson</surname><given-names>R.</given-names></name>
<name><surname>Hall</surname><given-names>R.A.</given-names></name>
<name><surname>Harty</surname><given-names>B.L.</given-names></name>
<name><surname>Kirchhoff</surname><given-names>C.</given-names></name>
<name><surname>Knapp</surname><given-names>B.</given-names></name>
<etal/>
</person-group><article-title>International Union of Basic and Clinical Pharmacology. XCIV. Adhesion G Protein-Coupled Receptors</article-title><source>Pharmacol. Rev.</source><year>2015</year><volume>67</volume><fpage>338</fpage><lpage>367</lpage><pub-id pub-id-type="doi">10.1124/pr.114.009647</pub-id><pub-id pub-id-type="pmid">25713288</pub-id>
</element-citation></ref><ref id="B11-toxins-17-00073"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lelyanova</surname><given-names>V.G.</given-names></name>
<name><surname>Thomson</surname><given-names>D.</given-names></name>
<name><surname>Ribchester</surname><given-names>R.R.</given-names></name>
<name><surname>Tonevitsky</surname><given-names>E.A.</given-names></name>
<name><surname>Ushkaryov</surname><given-names>Y.A.</given-names></name>
</person-group><article-title>Activation of &#x003b1;-Latrotoxin Receptors in Neuromuscular Synapses Leads to a Prolonged Splash Acetylcholine Release</article-title><source>Bull. Exp. Biol. Med.</source><year>2009</year><volume>147</volume><fpage>701</fpage><lpage>703</lpage><pub-id pub-id-type="doi">10.1007/s10517-009-0600-5</pub-id><pub-id pub-id-type="pmid">19902061</pub-id>
</element-citation></ref><ref id="B12-toxins-17-00073"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>D&#x000e9;ak</surname><given-names>F.</given-names></name>
<name><surname>Liu</surname><given-names>X.</given-names></name>
<name><surname>Khvotchev</surname><given-names>M.</given-names></name>
<name><surname>Li</surname><given-names>G.</given-names></name>
<name><surname>Kavalali</surname><given-names>E.T.</given-names></name>
<name><surname>Sugita</surname><given-names>S.</given-names></name>
<name><surname>Sudhof</surname><given-names>T.C.</given-names></name>
</person-group><article-title>&#x003b1;-Latrotoxin Stimulates a Novel Pathway of Ca<sup>2+</sup>-Dependent Synaptic Exocytosis Independent of the Classical Synaptic Fusion Machinery</article-title><source>J. Neurosci.</source><year>2009</year><volume>29</volume><fpage>8639</fpage><lpage>8648</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0898-09.2009</pub-id><pub-id pub-id-type="pmid">19587270</pub-id>
</element-citation></ref><ref id="B13-toxins-17-00073"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rohou</surname><given-names>A.</given-names></name>
<name><surname>Morris</surname><given-names>E.P.</given-names></name>
<name><surname>Makarova</surname><given-names>J.</given-names></name>
<name><surname>Tonevitsky</surname><given-names>A.G.</given-names></name>
<name><surname>Ushkaryov</surname><given-names>Y.A.</given-names></name>
</person-group><article-title>&#x003b1;-Latrotoxin Tetramers Spontaneously Form Two-Dimensional Crystals in Solution and Coordinated Multi-Pore Assemblies in Biological Membranes</article-title><source>Toxins</source><year>2024</year><volume>16</volume><elocation-id>248</elocation-id><pub-id pub-id-type="doi">10.3390/toxins16060248</pub-id><pub-id pub-id-type="pmid">38922143</pub-id>
</element-citation></ref><ref id="B14-toxins-17-00073"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Orlova</surname><given-names>E.V.</given-names></name>
<name><surname>Rahman</surname><given-names>M.A.</given-names></name>
<name><surname>Gowen</surname><given-names>B.</given-names></name>
<name><surname>Volynski</surname><given-names>K.E.</given-names></name>
<name><surname>Ashton</surname><given-names>A.C.</given-names></name>
<name><surname>Manser</surname><given-names>C.</given-names></name>
<name><surname>van Heel</surname><given-names>M.</given-names></name>
<name><surname>Ushkaryov</surname><given-names>Y.A.</given-names></name>
</person-group><article-title>Structure of &#x003b1;-Latrotoxin Oligomers Reveals That Divalent Cation-Dependent Tetramers Form Membrane Pores</article-title><source>Nat. Struct. Biol.</source><year>2000</year><volume>7</volume><fpage>48</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1038/71247</pub-id><pub-id pub-id-type="pmid">10625427</pub-id>
</element-citation></ref><ref id="B15-toxins-17-00073"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mironov</surname><given-names>S.L.</given-names></name>
<name><surname>Sokolov</surname><given-names>Y.V.</given-names></name>
<name><surname>Chanturiya</surname><given-names>A.N.</given-names></name>
<name><surname>Lishko</surname><given-names>V.K.</given-names></name>
</person-group><article-title>Channels Produced by Spider Venoms in Bilayer Lipid Membrane: Mechanisms of Ion Transport and Toxic Action</article-title><source>Biochim. Biophys. Acta</source><year>1986</year><volume>862</volume><fpage>185</fpage><lpage>198</lpage><pub-id pub-id-type="doi">10.1016/0005-2736(86)90482-7</pub-id><pub-id pub-id-type="pmid">2429700</pub-id>
</element-citation></ref><ref id="B16-toxins-17-00073"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Klink</surname><given-names>B.U.</given-names></name>
<name><surname>Alavizargar</surname><given-names>A.</given-names></name>
<name><surname>Kalyankumar</surname><given-names>K.S.</given-names></name>
<name><surname>Chen</surname><given-names>M.</given-names></name>
<name><surname>Heuer</surname><given-names>A.</given-names></name>
<name><surname>Gatsogiannis</surname><given-names>C.</given-names></name>
</person-group><article-title>Structural Basis of &#x003b1;-Latrotoxin Transition to a Cation-Selective Pore</article-title><source>Nat. Commun.</source><year>2024</year><volume>15</volume><fpage>8551</fpage><pub-id pub-id-type="doi">10.1038/s41467-024-52635-5</pub-id><pub-id pub-id-type="pmid">39362850</pub-id>
</element-citation></ref><ref id="B17-toxins-17-00073"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>McMahon</surname><given-names>H.T.</given-names></name>
<name><surname>Rosenthal</surname><given-names>L.</given-names></name>
<name><surname>Meldolesi</surname><given-names>J.</given-names></name>
<name><surname>Nicholls</surname><given-names>D.G.</given-names></name>
</person-group><article-title>&#x003b1;-Latrotoxin Releases Both Vesicular and Cytoplasmic Glutamate from Isolated Nerve Terminals</article-title><source>J. Neurochem.</source><year>1990</year><volume>55</volume><fpage>2039</fpage><lpage>2047</lpage><pub-id pub-id-type="doi">10.1111/j.1471-4159.1990.tb05793.x</pub-id><pub-id pub-id-type="pmid">1977887</pub-id>
</element-citation></ref><ref id="B18-toxins-17-00073"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Davletov</surname><given-names>B.A.</given-names></name>
<name><surname>Meunier</surname><given-names>F.A.</given-names></name>
<name><surname>Ashton</surname><given-names>A.C.</given-names></name>
<name><surname>Matsushita</surname><given-names>H.</given-names></name>
<name><surname>Hirst</surname><given-names>W.D.</given-names></name>
<name><surname>Lelianova</surname><given-names>V.G.</given-names></name>
<name><surname>Wilkin</surname><given-names>G.P.</given-names></name>
<name><surname>Dolly</surname><given-names>J.O.</given-names></name>
<name><surname>Ushkaryov</surname><given-names>Y.A.</given-names></name>
</person-group><article-title>Vesicle Exocytosis Stimulated by &#x003b1;-Latrotoxin Is Mediated by Latrophilin and Requires Both External and Stored Ca<sup>2+</sup></article-title><source>EMBO J.</source><year>1998</year><volume>17</volume><fpage>3909</fpage><lpage>3920</lpage><pub-id pub-id-type="doi">10.1093/emboj/17.14.3909</pub-id><pub-id pub-id-type="pmid">9670008</pub-id>
</element-citation></ref><ref id="B19-toxins-17-00073"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Volynski</surname><given-names>K.E.</given-names></name>
<name><surname>Capogna</surname><given-names>M.</given-names></name>
<name><surname>Ashton</surname><given-names>A.C.</given-names></name>
<name><surname>Thomson</surname><given-names>D.</given-names></name>
<name><surname>Orlova</surname><given-names>E.V.</given-names></name>
<name><surname>Manser</surname><given-names>C.F.</given-names></name>
<name><surname>Ribchester</surname><given-names>R.R.</given-names></name>
<name><surname>Ushkaryov</surname><given-names>Y.A.</given-names></name>
</person-group><article-title>Mutant &#x003b1;-Latrotoxin (LTXN4C) Does Not Form Pores and Causes Secretion by Receptor Stimulation. This Action Does Not Require Neurexins</article-title><source>J. Biol. Chem.</source><year>2003</year><volume>278</volume><fpage>31058</fpage><lpage>31066</lpage><pub-id pub-id-type="doi">10.1074/jbc.M210395200</pub-id><pub-id pub-id-type="pmid">12782639</pub-id>
</element-citation></ref><ref id="B20-toxins-17-00073"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Capogna</surname><given-names>M.</given-names></name>
<name><surname>Volynski</surname><given-names>K.E.</given-names></name>
<name><surname>Emptage</surname><given-names>N.J.</given-names></name>
<name><surname>Ushkaryov</surname><given-names>Y.A.</given-names></name>
</person-group><article-title>The &#x003b1;-Latrotoxin Mutant LTXN4C Enhances Spontaneous and Evoked Transmitter Release in CA3 Pyramidal Neurons</article-title><source>J. Neurosci.</source><year>2003</year><volume>23</volume><fpage>4044</fpage><lpage>4053</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.23-10-04044.2003</pub-id><pub-id pub-id-type="pmid">12764091</pub-id>
</element-citation></ref><ref id="B21-toxins-17-00073"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ichtchenko</surname><given-names>K.</given-names></name>
<name><surname>Khvotchev</surname><given-names>M.</given-names></name>
<name><surname>Kiyatkin</surname><given-names>N.</given-names></name>
<name><surname>Simpson</surname><given-names>L.</given-names></name>
<name><surname>Sugita</surname><given-names>S.</given-names></name>
<name><surname>S&#x000fc;dhof</surname><given-names>T.C.</given-names></name>
</person-group><article-title>&#x003b1;-Latrotoxin Action Probed with Recombinant Toxin: Receptors Recruit &#x003b1;-Latrotoxin but Do Not Transduce an Exocytotic Signal</article-title><source>EMBO J.</source><year>1998</year><volume>17</volume><fpage>6188</fpage><lpage>6199</lpage><pub-id pub-id-type="doi">10.1093/emboj/17.21.6188</pub-id><pub-id pub-id-type="pmid">9799228</pub-id>
</element-citation></ref><ref id="B22-toxins-17-00073"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rosenthal</surname><given-names>L.</given-names></name>
<name><surname>Zacchetti</surname><given-names>D.</given-names></name>
<name><surname>Madeddu</surname><given-names>L.</given-names></name>
<name><surname>Meldolesi</surname><given-names>J.</given-names></name>
</person-group><article-title>Mode of Action of &#x003b1;-Latrotoxin: Role of Divalent Cations in Ca<sup>2+</sup>-Dependent and Ca<sup>2+</sup>-Independent Effects Mediated by the Toxin</article-title><source>Mol. Pharmacol.</source><year>1990</year><volume>38</volume><fpage>917</fpage><lpage>923</lpage><pub-id pub-id-type="doi">10.1016/S0026-895X(25)09589-6</pub-id><pub-id pub-id-type="pmid">2174508</pub-id>
</element-citation></ref><ref id="B23-toxins-17-00073"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Liou</surname><given-names>J.</given-names></name>
<name><surname>Kim</surname><given-names>M.L.</given-names></name>
<name><surname>Heo</surname><given-names>W.D.</given-names></name>
<name><surname>Jones</surname><given-names>J.T.</given-names></name>
<name><surname>Myers</surname><given-names>J.W.</given-names></name>
<name><surname>Ferrell</surname><given-names>J.E.J.</given-names></name>
<name><surname>Meyer</surname><given-names>T.</given-names></name>
</person-group><article-title>STIM Is a Ca<sup>2+</sup> Sensor Essential for the Ca<sup>2+</sup>-Store-Depletion-Triggered Ca<sup>2+</sup> Influx</article-title><source>Curr. Biol.</source><year>2005</year><volume>15</volume><fpage>1235</fpage><lpage>1241</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2005.05.055</pub-id><pub-id pub-id-type="pmid">16005298</pub-id>
</element-citation></ref><ref id="B24-toxins-17-00073"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Huang</surname><given-names>G.N.</given-names></name>
<name><surname>Zeng</surname><given-names>W.</given-names></name>
<name><surname>Kim</surname><given-names>J.Y.</given-names></name>
<name><surname>Yuan</surname><given-names>J.P.</given-names></name>
<name><surname>Han</surname><given-names>L.</given-names></name>
<name><surname>Muallem</surname><given-names>S.</given-names></name>
<name><surname>Worley</surname><given-names>P.F.</given-names></name>
</person-group><article-title>STIM1 Carboxyl-Terminus Activates Native SOC, Icrac and TRPC1 Channels</article-title><source>Nat. Cell Biol.</source><year>2006</year><volume>8</volume><fpage>1003</fpage><lpage>1010</lpage><pub-id pub-id-type="doi">10.1038/ncb1454</pub-id><pub-id pub-id-type="pmid">16906149</pub-id>
</element-citation></ref><ref id="B25-toxins-17-00073"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Carrasco</surname><given-names>S.</given-names></name>
<name><surname>Meyer</surname><given-names>T.</given-names></name>
</person-group><article-title>STIM Proteins and the Endoplasmic Reticulum-Plasma Membrane Junctions</article-title><source>Annu. Rev. Biochem.</source><year>2011</year><volume>80</volume><fpage>973</fpage><lpage>1000</lpage><pub-id pub-id-type="doi">10.1146/annurev-biochem-061609-165311</pub-id><pub-id pub-id-type="pmid">21548779</pub-id>
</element-citation></ref><ref id="B26-toxins-17-00073"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kodakandla</surname><given-names>G.</given-names></name>
<name><surname>Akimzhanov</surname><given-names>A.M.</given-names></name>
<name><surname>Boehning</surname><given-names>D.</given-names></name>
</person-group><article-title>Regulatory Mechanisms Controlling Store-Operated Calcium Entry</article-title><source>Front. Physiol.</source><year>2023</year><volume>14</volume><elocation-id>259</elocation-id><pub-id pub-id-type="doi">10.3389/fphys.2023.1330259</pub-id></element-citation></ref><ref id="B27-toxins-17-00073"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rubaiy</surname><given-names>H.N.</given-names></name>
</person-group><article-title>ORAI Calcium Channels: Regulation, Function, Pharmacology, and Therapeutic Targets</article-title><source>Pharmaceuticals</source><year>2023</year><volume>16</volume><elocation-id>162</elocation-id><pub-id pub-id-type="doi">10.3390/ph16020162</pub-id><pub-id pub-id-type="pmid">37259313</pub-id>
</element-citation></ref><ref id="B28-toxins-17-00073"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Prakriya</surname><given-names>M.</given-names></name>
<name><surname>Lewis</surname><given-names>R.S.</given-names></name>
</person-group><article-title>Store-Operated Calcium Channels</article-title><source>Physiol Rev.</source><year>2015</year><volume>95</volume><fpage>1383</fpage><lpage>1436</lpage><pub-id pub-id-type="doi">10.1152/physrev.00020.2014</pub-id><pub-id pub-id-type="pmid">26400989</pub-id>
</element-citation></ref><ref id="B29-toxins-17-00073"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Koss</surname><given-names>D.J.</given-names></name>
<name><surname>Riedel</surname><given-names>G.</given-names></name>
<name><surname>Platt</surname><given-names>B.</given-names></name>
</person-group><article-title>Intracellular Ca<sup>2+</sup>stores Modulate SOCCs and NMDA Receptors via Tyrosine Kinases in Rat Hippocampal Neurons</article-title><source>Cell Calcium</source><year>2009</year><volume>46</volume><fpage>39</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.1016/j.ceca.2009.04.001</pub-id><pub-id pub-id-type="pmid">19423160</pub-id>
</element-citation></ref><ref id="B30-toxins-17-00073"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Stutzmann</surname><given-names>G.E.</given-names></name>
<name><surname>Mattson</surname><given-names>M.P.</given-names></name>
</person-group><article-title>Endoplasmic Reticulum Ca<sup>2+</sup> Handling in Excitable Cells in Health and Disease</article-title><source>Pharmacol. Rev.</source><year>2011</year><volume>63</volume><fpage>700</fpage><lpage>727</lpage><pub-id pub-id-type="doi">10.1124/pr.110.003814</pub-id><pub-id pub-id-type="pmid">21737534</pub-id>
</element-citation></ref><ref id="B31-toxins-17-00073"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tsang</surname><given-names>C.W.</given-names></name>
<name><surname>Elrick</surname><given-names>D.B.</given-names></name>
<name><surname>Charlton</surname><given-names>M.P.</given-names></name>
</person-group><article-title>&#x003b1;-Latrotoxin Releases Calcium in Frog Motor Nerve Terminals</article-title><source>J. Neurosci.</source><year>2000</year><volume>20</volume><fpage>8685</fpage><lpage>8692</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.20-23-08685.2000</pub-id><pub-id pub-id-type="pmid">11102474</pub-id>
</element-citation></ref><ref id="B32-toxins-17-00073"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jeffs</surname><given-names>G.J.</given-names></name>
<name><surname>Meloni</surname><given-names>B.P.</given-names></name>
<name><surname>Bakker</surname><given-names>A.J.</given-names></name>
<name><surname>Knuckey</surname><given-names>N.W.</given-names></name>
</person-group><article-title>The Role of the Na<sup>+</sup>/Ca<sup>2+</sup> Exchanger (NCX) in Neurons Following Ischaemia</article-title><source>J. Clin. Neurosci.</source><year>2007</year><volume>14</volume><fpage>507</fpage><lpage>514</lpage><pub-id pub-id-type="doi">10.1016/j.jocn.2006.07.013</pub-id><pub-id pub-id-type="pmid">17430774</pub-id>
</element-citation></ref><ref id="B33-toxins-17-00073"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Matuz-Mares</surname><given-names>D.</given-names></name>
<name><surname>Gonz&#x000e1;lez-Andrade</surname><given-names>M.</given-names></name>
<name><surname>Araiza-Villanueva</surname><given-names>M.G.</given-names></name>
<name><surname>Vilchis-Landeros</surname><given-names>M.M.</given-names></name>
<name><surname>V&#x000e1;zquez-Meza</surname><given-names>H.</given-names></name>
</person-group><article-title>Mitochondrial Calcium: Effects of Its Imbalance in Disease</article-title><source>Antioxidants</source><year>2022</year><volume>11</volume><elocation-id>801</elocation-id><pub-id pub-id-type="doi">10.3390/antiox11050801</pub-id><pub-id pub-id-type="pmid">35624667</pub-id>
</element-citation></ref><ref id="B34-toxins-17-00073"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Berridge</surname><given-names>M.J.</given-names></name>
<name><surname>Lipp</surname><given-names>P.</given-names></name>
<name><surname>Bootman</surname><given-names>M.D.</given-names></name>
</person-group><article-title>The Versatility and Universality of Calcium Signalling</article-title><source>Nat. Rev. Mol. Cell Biol.</source><year>2000</year><volume>1</volume><fpage>11</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1038/35036035</pub-id><pub-id pub-id-type="pmid">11413485</pub-id>
</element-citation></ref><ref id="B35-toxins-17-00073"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Palty</surname><given-names>R.</given-names></name>
<name><surname>Silverman</surname><given-names>W.F.</given-names></name>
<name><surname>Hershfinkel</surname><given-names>M.</given-names></name>
<name><surname>Caporale</surname><given-names>T.</given-names></name>
<name><surname>Sensi</surname><given-names>S.L.</given-names></name>
<name><surname>Parnis</surname><given-names>J.</given-names></name>
<name><surname>Nolte</surname><given-names>C.</given-names></name>
<name><surname>Fishman</surname><given-names>D.</given-names></name>
<name><surname>Shoshan-Barmatz</surname><given-names>V.</given-names></name>
<name><surname>Herrmann</surname><given-names>S.</given-names></name>
<etal/>
</person-group><article-title>NCLX Is an Essential Component of Mitochondrial Na<sup>+</sup>/Ca<sup>2+</sup> Exchange</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2010</year><volume>107</volume><fpage>436</fpage><lpage>441</lpage><pub-id pub-id-type="doi">10.1073/pnas.0908099107</pub-id><pub-id pub-id-type="pmid">20018762</pub-id>
</element-citation></ref><ref id="B36-toxins-17-00073"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Di Giuro</surname><given-names>C.M.L.</given-names></name>
<name><surname>Shrestha</surname><given-names>N.</given-names></name>
<name><surname>Malli</surname><given-names>R.</given-names></name>
<name><surname>Groschner</surname><given-names>K.</given-names></name>
<name><surname>van Breemen</surname><given-names>C.</given-names></name>
<name><surname>Fameli</surname><given-names>N.</given-names></name>
</person-group><article-title>Na<sup>+</sup>/Ca<sup>2+</sup> Exchangers and Orai Channels Jointly Refill Endoplasmic Reticulum (ER) Ca<sup>2+</sup> via ER Nanojunctions in Vascular Endothelial Cells</article-title><source>Pflugers Arch. Eur. J. Physiol.</source><year>2017</year><volume>469</volume><fpage>1287</fpage><lpage>1299</lpage><pub-id pub-id-type="doi">10.1007/s00424-017-1989-8</pub-id><pub-id pub-id-type="pmid">28497275</pub-id>
</element-citation></ref><ref id="B37-toxins-17-00073"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Michel</surname><given-names>L.Y.M.</given-names></name>
<name><surname>Hoenderop</surname><given-names>J.G.J.</given-names></name>
<name><surname>Bindels</surname><given-names>R.J.M.</given-names></name>
</person-group><article-title>Towards Understanding the Role of the Na<sup>+</sup>-Ca<sup>2+</sup> Exchanger Isoform 3</article-title><source>Rev. Physiol. Biochem. Pharmacol.</source><year>2015</year><volume>168</volume><fpage>31</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1007/112_2015_23</pub-id><pub-id pub-id-type="pmid">25851230</pub-id>
</element-citation></ref><ref id="B38-toxins-17-00073"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Boyman</surname><given-names>L.</given-names></name>
<name><surname>Williams</surname><given-names>G.S.B.</given-names></name>
<name><surname>Khananshvili</surname><given-names>D.</given-names></name>
<name><surname>Sekler</surname><given-names>I.</given-names></name>
<name><surname>Lederer</surname><given-names>W.J.</given-names></name>
</person-group><article-title>NCLX: The Mitochondrial Sodium Calcium Exchanger</article-title><source>J. Mol. Cell. Cardiol.</source><year>2013</year><volume>59</volume><fpage>205</fpage><lpage>213</lpage><pub-id pub-id-type="doi">10.1016/j.yjmcc.2013.03.012</pub-id><pub-id pub-id-type="pmid">23538132</pub-id>
</element-citation></ref><ref id="B39-toxins-17-00073"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>O&#x02019;Hanlon</surname><given-names>G.M.</given-names></name>
<name><surname>Humphreys</surname><given-names>P.D.</given-names></name>
<name><surname>Goldman</surname><given-names>R.S.</given-names></name>
<name><surname>Halstead</surname><given-names>S.K.</given-names></name>
<name><surname>Bullens</surname><given-names>R.W.M.M.</given-names></name>
<name><surname>Plomp</surname><given-names>J.J.</given-names></name>
<name><surname>Ushkaryov</surname><given-names>Y.</given-names></name>
<name><surname>Willison</surname><given-names>H.J.</given-names></name>
</person-group><article-title>Calpain Inhibitors Protect against Axonal Degeneration in a Model of Anti-Ganglioside Antibody-Mediated Motor Nerve Terminal Injury</article-title><source>Brain</source><year>2003</year><volume>126</volume><fpage>2497</fpage><lpage>2509</lpage><pub-id pub-id-type="doi">10.1093/brain/awg254</pub-id><pub-id pub-id-type="pmid">12937083</pub-id>
</element-citation></ref><ref id="B40-toxins-17-00073"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sons</surname><given-names>M.S.</given-names></name>
<name><surname>Plomp</surname><given-names>J.J.</given-names></name>
</person-group><article-title>Rab3A Deletion Selectively Reduces Spontaneous Neurotransmitter Release at the Mouse Neuromuscular Synapse</article-title><source>Brain Res.</source><year>2006</year><volume>1089</volume><fpage>126</fpage><lpage>134</lpage><pub-id pub-id-type="doi">10.1016/j.brainres.2006.03.055</pub-id><pub-id pub-id-type="pmid">16631140</pub-id>
</element-citation></ref><ref id="B41-toxins-17-00073"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ceccarelli</surname><given-names>B.</given-names></name>
<name><surname>Hurlbut</surname><given-names>W.P.</given-names></name>
</person-group><article-title>Ca<sup>2+</sup>-Dependent Recycling of Synaptic Vesicles at the Frog Neuromuscular Junction</article-title><source>J. Cell Biol.</source><year>1980</year><volume>87</volume><fpage>297</fpage><lpage>303</lpage><pub-id pub-id-type="doi">10.1083/jcb.87.1.297</pub-id><pub-id pub-id-type="pmid">6252215</pub-id>
</element-citation></ref><ref id="B42-toxins-17-00073"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Valtorta</surname><given-names>F.</given-names></name>
<name><surname>Fesce</surname><given-names>R.</given-names></name>
<name><surname>Grohovaz</surname><given-names>F.</given-names></name>
<name><surname>Haimann</surname><given-names>C.</given-names></name>
<name><surname>Hurlbut</surname><given-names>W.P.</given-names></name>
<name><surname>Iezzi</surname><given-names>N.</given-names></name>
<name><surname>Torri-Tarelli</surname><given-names>F.</given-names></name>
<name><surname>Villa</surname><given-names>A.</given-names></name>
<name><surname>Ceccarelli</surname><given-names>B.</given-names></name>
</person-group><article-title>Neurotransmutter Release and Synaptic Vesicle Recycling</article-title><source>Neuroscience</source><year>1990</year><volume>35</volume><fpage>477</fpage><lpage>489</lpage><pub-id pub-id-type="doi">10.1016/0306-4522(90)90323-V</pub-id><pub-id pub-id-type="pmid">1974329</pub-id>
</element-citation></ref><ref id="B43-toxins-17-00073"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Anantharam</surname><given-names>A.</given-names></name>
<name><surname>Kreutzberger</surname><given-names>A.J.B.</given-names></name>
</person-group><article-title>Unraveling the Mechanisms of Calcium-Dependent Secretion</article-title><source>J. Gen. Physiol.</source><year>2019</year><volume>151</volume><fpage>417</fpage><lpage>434</lpage><pub-id pub-id-type="doi">10.1085/jgp.201812298</pub-id><pub-id pub-id-type="pmid">30782604</pub-id>
</element-citation></ref><ref id="B44-toxins-17-00073"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ashton</surname><given-names>A.C.</given-names></name>
<name><surname>Volynski</surname><given-names>K.E.</given-names></name>
<name><surname>Lelianova</surname><given-names>V.G.</given-names></name>
<name><surname>Orlova</surname><given-names>E.V.</given-names></name>
<name><surname>Van Renterghem</surname><given-names>C.</given-names></name>
<name><surname>Canepari</surname><given-names>M.</given-names></name>
<name><surname>Seagar</surname><given-names>M.</given-names></name>
<name><surname>Ushkaryov</surname><given-names>Y.A.</given-names></name>
</person-group><article-title>&#x003b1;-Latrotoxin, Acting via Two Ca<sup>2+</sup>-Dependent Pathways, Triggers Exocytosis of Two Pools of Synaptic Vesicles</article-title><source>J. Biol. Chem.</source><year>2001</year><volume>276</volume><fpage>44695</fpage><lpage>44703</lpage><pub-id pub-id-type="doi">10.1074/jbc.M108088200</pub-id><pub-id pub-id-type="pmid">11572875</pub-id>
</element-citation></ref><ref id="B45-toxins-17-00073"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Deri</surname><given-names>Z.</given-names></name>
<name><surname>Dam-Vizi</surname><given-names>V.</given-names></name>
</person-group><article-title>Detection of Intracellular Free Na<sup>+</sup> Concentration of Synaptosomes by a Fluorescent Indicator, Na(+)-Binding Benzofuran Isophthalate: The Effect of Veratridine, Ouabain, and &#x003b1;-Latrotoxin</article-title><source>J. Neurochem.</source><year>1993</year><volume>61</volume><fpage>818</fpage><lpage>825</lpage><pub-id pub-id-type="doi">10.1111/j.1471-4159.1993.tb03592.x</pub-id><pub-id pub-id-type="pmid">8360686</pub-id>
</element-citation></ref><ref id="B46-toxins-17-00073"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Prakriya</surname><given-names>M.</given-names></name>
<name><surname>Lewis</surname><given-names>R.S.</given-names></name>
</person-group><article-title>Separation and Characterization of Currents through Store-Operated CRAC Channels and Mg<sup>2+</sup>-Inhibited Cation (MIC) Channels</article-title><source>J. Gen. Physiol.</source><year>2002</year><volume>119</volume><fpage>487</fpage><lpage>507</lpage><pub-id pub-id-type="doi">10.1085/jgp.20028551</pub-id><pub-id pub-id-type="pmid">11981025</pub-id>
</element-citation></ref><ref id="B47-toxins-17-00073"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Song</surname><given-names>M.</given-names></name>
<name><surname>Chen</surname><given-names>D.</given-names></name>
<name><surname>Yu</surname><given-names>S.P.</given-names></name>
</person-group><article-title>The TRPC Channel Blocker SKF 96365 Inhibits Glioblastoma Cell Growth by Enhancing Reverse Mode of the Na<sup>+</sup>/Ca<sup>2+</sup> Exchanger and Increasing Intracellular Ca<sup>2+</sup></article-title><source>Br. J. Pharmacol.</source><year>2014</year><volume>171</volume><fpage>3432</fpage><lpage>3447</lpage><pub-id pub-id-type="doi">10.1111/bph.12691</pub-id><pub-id pub-id-type="pmid">24641279</pub-id>
</element-citation></ref><ref id="B48-toxins-17-00073"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Michelena</surname><given-names>P.</given-names></name>
<name><surname>de la Fuente</surname><given-names>M.T.</given-names></name>
<name><surname>Vega</surname><given-names>T.</given-names></name>
<name><surname>Lara</surname><given-names>B.</given-names></name>
<name><surname>Lopez</surname><given-names>M.G.</given-names></name>
<name><surname>Gandia</surname><given-names>L.</given-names></name>
<name><surname>Garcia</surname><given-names>A.G.</given-names></name>
</person-group><article-title>Drastic Facilitation by &#x003b1;-Latrotoxin of Bovine Chromaffin Cell Exocytosis without Measurable Enhancement of Ca<sup>2+</sup> Entry or [Ca<sup>2+</sup>]I</article-title><source>J. Physiol</source><year>1997</year><volume>502</volume><issue-part>Pt 3</issue-part><fpage>481</fpage><lpage>496</lpage><pub-id pub-id-type="doi">10.1111/j.1469-7793.1997.481bj.x</pub-id><pub-id pub-id-type="pmid">9279802</pub-id>
</element-citation></ref><ref id="B49-toxins-17-00073"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Malli</surname><given-names>R.</given-names></name>
<name><surname>Frieden</surname><given-names>M.</given-names></name>
<name><surname>Osibow</surname><given-names>K.</given-names></name>
<name><surname>Zoratti</surname><given-names>C.</given-names></name>
<name><surname>Mayer</surname><given-names>M.</given-names></name>
<name><surname>Demaurex</surname><given-names>N.</given-names></name>
<name><surname>Graier</surname><given-names>W.F.</given-names></name>
</person-group><article-title>Sustained Ca<sup>2+</sup> Transfer across Mitochondria Is Essential for Mitochondrial Ca<sup>2+</sup> Buffering, Store-Operated Ca<sup>2+</sup> Entry, and Ca<sup>2+</sup> Store Refilling</article-title><source>J. Biol. Chem.</source><year>2003</year><volume>278</volume><fpage>44769</fpage><lpage>44779</lpage><pub-id pub-id-type="doi">10.1074/jbc.M302511200</pub-id><pub-id pub-id-type="pmid">12941956</pub-id>
</element-citation></ref><ref id="B50-toxins-17-00073"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Duszy&#x00144;ski</surname><given-names>J.</given-names></name>
<name><surname>Kozie&#x00142;</surname><given-names>R.</given-names></name>
<name><surname>Brutkowski</surname><given-names>W.</given-names></name>
<name><surname>Szczepanowska</surname><given-names>J.</given-names></name>
<name><surname>Zab&#x00142;ocki</surname><given-names>K.</given-names></name>
</person-group><article-title>The Regulatory Role of Mitochondria in Capacitative Calcium Entry</article-title><source>Biochim. Biophys. Acta Bioenerg.</source><year>2006</year><volume>1757</volume><fpage>380</fpage><lpage>387</lpage><pub-id pub-id-type="doi">10.1016/j.bbabio.2006.04.017</pub-id></element-citation></ref><ref id="B51-toxins-17-00073"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ashton</surname><given-names>A.C.</given-names></name>
<name><surname>Rahman</surname><given-names>M.A.</given-names></name>
<name><surname>Volynski</surname><given-names>K.E.</given-names></name>
<name><surname>Manser</surname><given-names>C.</given-names></name>
<name><surname>Orlova</surname><given-names>E.V.</given-names></name>
<name><surname>Matsushita</surname><given-names>H.</given-names></name>
<name><surname>Davletov</surname><given-names>B.A.</given-names></name>
<name><surname>Van Heel</surname><given-names>M.</given-names></name>
<name><surname>Grishin</surname><given-names>E.V.</given-names></name>
<name><surname>Ushkaryov</surname><given-names>Y.A.</given-names></name>
</person-group><article-title>Tetramerisation of &#x003b1;-Latrotoxin by Divalent Cations Is Responsible for Toxin-Induced Non-Vesicular Release and Contributes to the Ca<sup>2+</sup>-Dependent Vesicular Exocytosis from Synaptosomes</article-title><source>Biochimie</source><year>2000</year><volume>82</volume><fpage>453</fpage><lpage>468</lpage><pub-id pub-id-type="doi">10.1016/S0300-9084(00)00199-1</pub-id><pub-id pub-id-type="pmid">10865132</pub-id>
</element-citation></ref><ref id="B52-toxins-17-00073"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Volynski</surname><given-names>K.E.</given-names></name>
<name><surname>Nosyreva</surname><given-names>E.D.</given-names></name>
<name><surname>Ushkaryov</surname><given-names>Y.A.</given-names></name>
<name><surname>Grishin</surname><given-names>E.V.</given-names></name>
</person-group><article-title>Functional Expression of &#x003b1;-Latrotoxin in Baculovirus System</article-title><source>FEBS Lett.</source><year>1999</year><volume>442</volume><fpage>25</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1016/S0014-5793(98)01624-X</pub-id><pub-id pub-id-type="pmid">9923597</pub-id>
</element-citation></ref></ref-list></back><floats-group><fig position="float" id="toxins-17-00073-f001"><label>Figure 1</label><caption><p>&#x003b1;LTX actions do not require extracellular Ca<sup>2+</sup> but strictly depend on intracellular Ca<sup>2+</sup>. (<bold>a</bold>) Examples of the effect of 0.5 nM &#x003b1;LTX on the frequency of spontaneous MEPPs in mouse neuromuscular preparations in the absence of Ca<sup>2+</sup><sub>e</sub>, continuously recorded from individual muscle fibers. (<bold>b</bold>) The control experimental protocol: initial incubation with 2 mM Ca<sup>2+</sup><sub>e</sub>; removal of Ca<sup>2+</sup><sub>e</sub>; addition of 0.5 nM &#x003b1;LTX; reintroduction of 2 mM Ca<sup>2+</sup><sub>e</sub>. (<bold>c</bold>) Representative <italic toggle="yes">V</italic>m recordings during respective experimental stages. (<bold>d</bold>,<bold>e</bold>) Mean MEPP frequencies and amplitudes during the experimental stages as indicated below. (<bold>f</bold>) The Ca<sup>2+</sup><sub>cyt</sub> chelation protocol: initial incubation in a Ca<sup>2+</sup><sub>e</sub>-free buffer; incubation with 200&#x02013;500 &#x003bc;M BAPTA-AM; two extended washing steps with a Ca<sup>2+</sup>-free buffer; addition of 0.5 nM &#x003b1;LTX; reintroduction of 2 mM Ca<sup>2+</sup><sub>e</sub>. (<bold>g</bold>) Representative <italic toggle="yes">V</italic>m recordings under the experimental conditions indicated. (<bold>h</bold>,<bold>i</bold>) Mean MEPP frequencies and amplitudes during respective experimental stages. The bars are the means &#x000b1; <italic toggle="yes">SEM</italic>; the bar colors correspond to protocol phases; the underlying data points are shown as white circles; asterisks show statistical significance compared to Ca<sup>2+</sup><sub>e</sub>-free control, unless indicated by lines; the blue asterisk in (<bold>h</bold>) compares the values indicated by the two blue bars; *, <italic toggle="yes">p</italic> &#x0003c; 0.05; **, <italic toggle="yes">p</italic> &#x0003c; 0.01; ***, <italic toggle="yes">p</italic> &#x0003c; 0.001; ****, <italic toggle="yes">p</italic> &#x0003c; 0.0001; <italic toggle="yes">NS</italic>, non-significant; for each condition shown, <italic toggle="yes">n</italic> = 9&#x02013;43 individual muscle fibers, from 3 to 4 independent neuromuscular preparations.</p></caption><graphic xlink:href="toxins-17-00073-g001" position="float"/></fig><fig position="float" id="toxins-17-00073-f002"><label>Figure 2</label><caption><p>The depletion of intracellular Ca<sup>2+</sup> stores inhibits the Ca<sup>2+</sup><sub>e</sub>-independent actions of &#x003b1;LTX. (<bold>a</bold>) An example of the effect of TG and subsequent &#x003b1;LTX on the frequency of spontaneous MEPPs. The experimental protocol shown above the trace included the following phases: initial incubation in a Ca<sup>2+</sup><sub>e</sub>-free buffer; addition of 10 &#x003bc;M TG; addition of 0.5 nM &#x003b1;LTX; and reintroduction of 2 mM Ca<sup>2+</sup><sub>e</sub>. (<bold>b</bold>) Representative <italic toggle="yes">V</italic>m recordings during respective experimental stages. (<bold>c</bold>) Average MEPPs in the absence and presence of TG, in the absence of Ca<sup>2+</sup><sub>e</sub>. (<bold>d</bold>,<bold>e</bold>) Mean MEPP amplitudes and half-widths during the indicated experimental stages. (<bold>f</bold>) Mean MEPP frequencies&#x02019; respective experimental stages. The bars are the means &#x000b1; <italic toggle="yes">SEM</italic>; the bar colors correspond to protocol phases; asterisks show statistical significance compared to Ca<sup>2+</sup><sub>e</sub>-free control; the underlying data points are shown as white circles; *, <italic toggle="yes">p</italic> &#x0003c; 0.05; **, <italic toggle="yes">p</italic> &#x0003c; 0.01; ***, <italic toggle="yes">p</italic> &#x0003c; 0.001; ****, <italic toggle="yes">p</italic> &#x0003c; 0.0001; <italic toggle="yes">NS</italic>, non-significant; <italic toggle="yes">n</italic> = 12&#x02013;36 individual muscle fibers from 4 to 7 independent neuromuscular preparations.</p></caption><graphic xlink:href="toxins-17-00073-g002" position="float"/></fig><fig position="float" id="toxins-17-00073-f003"><label>Figure 3</label><caption><p>ADGRL1 constructs expressed in NB2a cells specifically bind &#x003b1;LTX. (<bold>a</bold>) The structures and membrane topologies of the two ADGRL1 constructs. (<bold>b</bold>) Stable expression of the ADGRL1 constructs in NB2a cells. Whole-cell lysates were separated by 8% SDS-PAGE, blotted and probed with an anti-V5 antibody. Top, a typical Western blot representative of four independent experiments. Bottom, quantification of the expression data; <italic toggle="yes">n</italic> = 4. NB2a, un-transfected cells. (<bold>c</bold>) The expressed ADGRL1 constructs bind &#x003b1;LTX. Transfected cells were incubated with 5 nM &#x003b1;LTX and centrifuged. The supernatants and cell pellets were separated by SDS-PAGE, blotted and probed with an anti-LTX antibody. Top, a representative Western blot showing unbound &#x003b1;LTX in the supernatants and receptor-bound &#x003b1;LTX in the cell pellets. Bottom, relative amounts of &#x003b1;LTX bound to respective cells; <italic toggle="yes">n</italic> = 3. *, <italic toggle="yes">p</italic> &#x0003c; 0.05; **, <italic toggle="yes">p</italic> &#x0003c; 0.01; ****, <italic toggle="yes">p</italic> &#x0003c; 0.0001.</p></caption><graphic xlink:href="toxins-17-00073-g003" position="float"/></fig><fig position="float" id="toxins-17-00073-f004"><label>Figure 4</label><caption><p>&#x003b1;LTX releases intracellular Ca<sup>2+</sup> and triggers vast Ca<sup>2+</sup> influx in cells expressing full-size receptors only. (<bold>a</bold>) A representative trace of changes in Ca<sup>2+</sup> fluorescence in Fluo-4-loaded NB2a cells treated with 0.3 &#x003bc;M TG. The following characteristic stages are indicated: in the absence of Ca<sup>2+</sup><sub>e</sub>, TG induces intracellular Ca<sup>2+</sup> release; reintroduction of Ca<sup>2+</sup><sub>e</sub> leads to a transient Ca<sup>2+</sup> influx (Ca<sup>2+</sup> peak) and Ca<sup>2+</sup><sub>cyt</sub> equilibrium (Ca<sup>2+</sup> Eq). (<bold>b</bold>) Representative fluorescence traces showing &#x003b1;LTX-mediated effects in control cells and cells expressing LPH. (<bold>c</bold>) Relative Ca<sup>2+</sup> release measured at end of Ca<sup>2+</sup><sub>e</sub>-free period. (<bold>d</bold>) Amplitude of transient Ca<sup>2+</sup> peak on the addition of Ca<sup>2+</sup><sub>e</sub>. (<bold>e</bold>) Relative Ca<sup>2+</sup><sub>cyt</sub> Eq in the presence of Ca<sup>2+</sup><sub>e</sub>. Bars show the means &#x000b1; <italic toggle="yes">SEM</italic> from 3 to 7 independent experiments performed in triplicate. *, <italic toggle="yes">p</italic> &#x0003c; 0.05; ***, <italic toggle="yes">p</italic> &#x0003c; 0.001; ****, <italic toggle="yes">p</italic> &#x0003c; 0.0001; <italic toggle="yes">NS</italic>, non-significant.</p></caption><graphic xlink:href="toxins-17-00073-g004" position="float"/></fig><fig position="float" id="toxins-17-00073-f005"><label>Figure 5</label><caption><p>&#x003b1;LTX-mediated Ca<sup>2+</sup><sub>cyt</sub> regulation involves signaling and non-signaling mechanisms. (<bold>a</bold>) LPH- and &#x00394;LPH-expressing NB2a cells were incubated in Ca<sup>2+</sup>-free buffer, then treated with 1 nM &#x003b1;LTX, and exposed to 2 mM Ca<sup>2+</sup><sub>e</sub>. The fluorescence traces shown are the averages of three replicates and representative of four independent experiments. (<bold>b</bold>) Initial rate of intracellular Ca<sup>2+</sup> release. (<bold>c</bold>) Relative Ca<sup>2+</sup> release at the end of Ca<sup>2+</sup><sub>e</sub>-free period. (<bold>d</bold>) Amplitude of the transient Ca<sup>2+</sup> influx peak in the presence of Ca<sup>2+</sup><sub>e</sub>. (<bold>e</bold>) Relative Ca<sup>2+</sup> Eq in the presence of Ca<sup>2+</sup><sub>e</sub>. Bars show the means &#x000b1; <italic toggle="yes">SEM</italic>; *, <italic toggle="yes">p</italic> &#x0003c; 0.05; ***, <italic toggle="yes">p</italic> &#x0003c; 0.001; ****, <italic toggle="yes">p</italic> &#x0003c; 0.0001; <italic toggle="yes">NS</italic>, non-significant.</p></caption><graphic xlink:href="toxins-17-00073-g005" position="float"/></fig><fig position="float" id="toxins-17-00073-f006"><label>Figure 6</label><caption><p>In model cells, &#x003b1;LTX does not release Ca<sup>2+</sup> from the ER. (<bold>a</bold>) LPH- and &#x00394;LPH-expressing NB2a cells were treated with 0.3 &#x003bc;M TG, then stimulated with 1 nM &#x003b1;LTX and exposed to 2 mM Ca<sup>2+</sup><sub>e</sub>. Representative fluorescence traces show the averages of three replicates. (<bold>b</bold>&#x02013;<bold>e</bold>) Ca<sup>2+</sup><sub>cyt</sub> changes relative to the &#x003b1;LTX-induced effects in the LPH-expressing cells (blue bars). (<bold>b</bold>) Amplitudes of &#x003b1;LTX-mediated Ca<sup>2+</sup> release. (<bold>c</bold>) Rates of Ca<sup>2+</sup> release during the Ca<sup>2+</sup>-free period. (<bold>d</bold>) Amplitudes of transient Ca<sup>2+</sup> influx in the presence of Ca<sup>2+</sup><sub>e</sub>. (<bold>e</bold>) Levels of Ca<sup>2+</sup><sub>e</sub> Eq. Asterisks show statistical significance compared to LPH-cells + &#x003b1;LTX (blue bars), other comparisons are shown by horizontal lines. Bars are the means &#x000b1; <italic toggle="yes">SEM</italic> (<italic toggle="yes">n</italic> = 3&#x02013;4); *, <italic toggle="yes">p</italic> &#x0003c; 0.05; ***, <italic toggle="yes">p</italic> &#x0003c; 0.001; ****, <italic toggle="yes">p</italic> &#x0003c; 0.0001; <italic toggle="yes">NS</italic>, non-significant.</p></caption><graphic xlink:href="toxins-17-00073-g006" position="float"/></fig><fig position="float" id="toxins-17-00073-f007"><label>Figure 7</label><caption><p>The &#x003b1;LTX pore regulates [Ca<sup>2+</sup>]<sub>cyt</sub> by inducing Na<sup>+</sup> influx, while receptor-mediated action does not require Na<sup>+</sup> influx. (<bold>a</bold>) LPH- and &#x00394;LPH-expressing NB2a cells were incubated in buffer containing Na<sup>+</sup> or the Na<sup>+</sup> substitute NMDG, then stimulated with 1 nM &#x003b1;LTX and exposed to 2 mM Ca<sup>2+</sup><sub>e</sub>. Representative fluorescence traces show the averages of three replicates. (<bold>b</bold>&#x02013;<bold>e</bold>) Ca<sup>2+</sup><sub>cyt</sub> changes relative to the &#x003b1;LTX-induced effects in the LPH-expressing cells in the presence of Na<sup>+</sup>. (<bold>b</bold>) Amplitudes of &#x003b1;LTX-mediated Ca<sup>2+</sup> release. (<bold>c</bold>) Amplitudes of transient Ca<sup>2+</sup> influx peaks. (<bold>d</bold>) Levels of Ca<sup>2+</sup><sub>e</sub> Eq at the end of experiment. The bars are the means &#x000b1; <italic toggle="yes">SEM</italic> (<italic toggle="yes">n</italic> = 2&#x02013;5); the asterisks show statistical significance compared to the LPH/&#x003b1;LTX/Na<sup>+</sup> condition, other comparisons are shown by horizontal lines. *, <italic toggle="yes">p</italic> &#x0003c; 0.05; **, <italic toggle="yes">p</italic> &#x0003c; 0.01; ***, <italic toggle="yes">p</italic> &#x0003c; 0.001; <italic toggle="yes">NS</italic>, non-significant.</p></caption><graphic xlink:href="toxins-17-00073-g007" position="float"/></fig><fig position="float" id="toxins-17-00073-f008"><label>Figure 8</label><caption><p>SKF inhibits &#x003b1;LTX-induced Ca<sup>2+</sup> release and subsequent Ca<sup>2+</sup> influx. (<bold>a</bold>) LPH-expressing NB2a cells were incubated in buffer containing 145 mM Na<sup>+</sup> or 145 mM NMDG. The cells were then treated with 100 &#x003bc;M SKF, stimulated with 1 nM &#x003b1;LTX and exposed to 2 mM Ca<sup>2+</sup><sub>e</sub>. The fluorescence traces are the averages of three replicates and are representative of five independent experiments. (<bold>b</bold>&#x02013;<bold>e</bold>) Ca<sup>2+</sup><sub>cyt</sub> changes relative to the &#x003b1;LTX-induced effects in the LPH-expressing cells in the presence of Na<sup>+</sup>. (<bold>b</bold>) SKF-induced Ca<sup>2+</sup> release. (<bold>c</bold>) &#x003b1;LTX-mediated Ca<sup>2+</sup> release with and without prior SKF treatment. (<bold>d</bold>) Amplitude of the Ca<sup>2+</sup> peaks under respective conditions. (<bold>e</bold>) Ca<sup>2+</sup> Eq levels after respective treatments. The bars are the means &#x000b1; <italic toggle="yes">SEM</italic> (<italic toggle="yes">n</italic> = 5); the asterisks show statistical significance compared to LPH/Na<sup>+</sup>/&#x003b1;LTX, other comparisons are shown by horizontal lines; *, <italic toggle="yes">p</italic> &#x0003c; 0.05; **, <italic toggle="yes">p</italic> &#x0003c; 0.01; ***, <italic toggle="yes">p</italic> &#x0003c; 0.001; <italic toggle="yes">NS</italic>, non-significant.</p></caption><graphic xlink:href="toxins-17-00073-g008" position="float"/></fig><fig position="float" id="toxins-17-00073-f009"><label>Figure 9</label><caption><p>Dual actions of &#x003b1;LTX on Ca<sup>2+</sup><sub>cyt</sub> in presynaptic nerve terminals that lead to neurotransmitter release. (<bold>a</bold>) Idealized Ca<sup>2+</sup><sub>cyt</sub> dynamics induced by TG and the two LTX actions (after subtracting control traces). (i) TG blocks SERCA and causes Ca<sup>2+</sup> release from the ER, which activates a transient SOCE upon reintroduction of Ca<sup>2+</sup><sub>e</sub>; Ca<sup>2+</sup><sub>cyt</sub> decays due to NCX activity. (ii) Combined &#x003b1;LTX activity, consisting of the ADGRL1- and pore-mediated effects. (iii) Receptor-dependent &#x003b1;LTX action calculated by subtracting the &#x003b1;LTX pore-mediated effect (iv) from the combined &#x003b1;LTX actions (ii). Receptor-mediated signaling causes a slow release of Ca<sup>2+</sup> from intracellular stores and subsequent opening of a large pool of SOCCs. Reintroduction of Ca<sup>2+</sup><sub>e</sub> leads to a transient SOCE that exceeds that caused by TG. ADGRL1 signaling also opens non-inactivating Ca<sup>2+</sup> channels that contribute to the elevated Ca<sup>2+</sup><sub>cyt</sub> after SOCE. (iv) &#x003b1;LTX pore-mediated effects based on our experiments with &#x00394;LPH and NMDG. &#x003b1;LTX pores mediate the influx of Na<sup>+</sup><sub>e</sub>, which reverses NCX. Reversal of NCX located on the Ca<sup>2+</sup> stores (ER and MC) and cell membrane leads to a slow increase in [Ca<sup>2+</sup>]<sub>cyt</sub>, and inhibits Ca<sup>2+</sup><sub>cyt</sub> extrusion. Upon reintroduction of Ca<sup>2+</sup><sub>e</sub>, Ca<sup>2+</sup><sub>e</sub> influx via &#x003b1;LTX pores and inhibition of Ca<sup>2+</sup><sub>cyt</sub> extrusion elevate the [Ca<sup>2+</sup>]<sub>cyt</sub> further. (<bold>b</bold>) A model of &#x003b1;LTX action. &#x003b1;LTX binds and activates ADGRL1, and forms pores in the cell membrane. Na<sup>+</sup> and Ca<sup>2+</sup> enter though the &#x003b1;LTX pores. Elevated [Na<sup>+</sup>]<sub>cyt</sub> reverses NCX located on the MC, ER, and cell membrane. This releases Ca<sup>2+</sup> from the MC and ER, and inhibits Ca<sup>2+</sup><sub>cyt</sub> extrusion. The pore-mediated [Ca<sup>2+</sup>]<sub>cyt</sub> increase triggers exocytosis of synaptic vesicles (SV). &#x003b1;LTX also activates G protein signaling via ADGRL1, resulting in Ca<sup>2+</sup> release from the ER and/or other stores, and the activation of SOCCs (via store depletion and/or by direct signaling). However, ADGRL1-mediated &#x003b1;LTX action requires Ca<sup>2+</sup> influx via SOCCs to develop its full effect and cause a burst-like release of SVs. IP<sub>3</sub>, inositol 1,4,5-trisphosphate; IP<sub>3</sub>R, IP<sub>3</sub> receptor; NCLX, Na<sup>+</sup>-Ca<sup>2+</sup> exchanger of the internal MC membrane; STIM, proteins detecting Ca<sup>2+</sup> release from ER; SV, synaptic vesicles.</p></caption><graphic xlink:href="toxins-17-00073-g009" position="float"/></fig></floats-group></article>